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Food is one of the basic human needs. The importance of food goes beyond its material value 
and the physiological need to eat. In every culture and for all individuals, it takes on a 
symbolic value. From birth, food conceptualizes the idea of giving nourishment and creates 
the first fundamental social relationship between mother and son. Many aspects of different 
cultures and traditions are transmitted during and through the sharing of food. The meal itself 
is an important moment of socialization through which relationships are built and hierarchies 
established, being an integral part of the education for each. Finally, the choice of food itself 
characterizes each culture in a specific way. For example food expresses aspects of the habits 
of a people based on geographical location, access to raw materials and the religious beliefs 
and history of each country
1
.  
1.2 Nutrition and diseases 
Nutrition is the intake of food, considered in relation to the body’s dietary needs. Good 
nutrition is considered an adequate, well balanced diet combined with regular physical 
activity, the cornerstone of good health. Poor nutrition can lead to reduced immunity, 
increased susceptibility to disease, impaired physical and mental development and reduced 
productivity. According to the World Health Organization (WHO), about one-third of all 
cardiovascular diseases and cancers could be prevented through a healthy and balanced diet, 
thus preventing three million deaths each year simply by consuming a sufficient quantity of 
fresh fruits and vegetables
2
. The human body needs all types of nutrients to function 
properly. Some are essential to meet energy needs, to sustain the continuous replacement of 
cells and elements of the body, to perform physiological processes and to have protective 
functions. For this reason, a healthy diet should be maintained, being both varied and 
balanced. In spite of the fact that life expectancy has increased markedly during the last few 
centuries, worldwide populations may benefit from optimizing their nutrition to reduce the 
incidence of obesity, type 2 diabetes mellitus (T2D), cardiovascular diseases as well as 
several types of cancer and infectious diseases. Nutritional science should be focused on 
preventing the development of these diseases, as well as supporting the repair processes 
important for curing diseases that are already fully developed
3
. Research of traditional 
nutrition has contributed significantly to modern biomedicine and has promoted a prolonged 
life expectancy. However, there is still a large space for improving diet and health for many 
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groups in economically developing as well as developed countries. This potential can be 
exploited through the design of good studies and the application of new and advanced 
techniques, particularly those based on molecular methods and advanced biostatistics
4
.  
1.3 How it is changing the concept of nutrition 
Good nutrition is of fundamental importance for normal growth and development and in the 
maintenance of health throughout life. Nutrition is highly complex. It is a concert of 
multitudes of essential nutrients both known and unknown, chemical compounds without 
known biological functions, an array of different cell types and the extensive microbiological 
activity in the intestine, combined with  components of genetic and epigenetic variation. All 
these variables allow for an extensive variation between individuals as well as between 
different physiological states such as fasted, fed, cold, warm, rested, exercised, exhausted, 
male and female, menstrual cycle, pregnant, lactating and age, ranging from newborn to 
veteran. This extensive complexity of nutritional science demands advanced approaches to 
unravel the relations between diet and health for different ages, sexes, environmental 
conditions and so forth
5,6
. Nutrients have a global role (fig. 1). They can influence gene 
expression, either directly such as ligands for nuclear receptors or by inducing epigenetic 
modifications. However, nutrients are also essential building blocks (essential amino acids), 
they may act as coenzymes in chemical reactions (vitamins), can be converted into bioactive 




New and advanced molecular techniques provide opportunities in nutritional science. These 
technologies are often based on the different “omics” such as: genomics, epigenomics, 
transcriptomics, proteomics and metabolomics. With respect to these molecular methods, 
which can be applied to nutrition research, proteomics will be well explained in section 1.5
8
. 
Nutrigenetics and nutrigenomics are nascent areas that are evolving quickly and riding on the 
wave of “personalized medicine” that is providing opportunities in the discovery and 
development of nutraceutical compounds
9,10
.  
The human genome sequence and sequences of model organisms, provide the equivalent of 
comprehensive blueprints and lists of parts that describe dynamic networks and the basis for 
understanding their responses to external and internal perturbations. Unfolding the 
interrelationships between genes, gene products and dietary habits is fundamental for 























Figure 1. Dietary factors may interact with multiple biological processes. Nutrients interact with genes and alter 
functional outcomes (genomics); nutrients may induce epigenetic changes (epigenomics); nutrients may 
influence gene expression  (transcriptomics); nutrients may post-translationally modify proteins (proteomics) 
and nutrients may change the metabolomic signature in the blood (metabolomics). Modified by  Frode Norheim et al.4 
 
More accurate assessment of the inputs to human health and the consequences of those inputs 
measured by transcriptomics, proteomics and metabolomics analyses, would bring 
personalized health/diet to practice far faster than waiting for predictions from genetic 
variations. It is widely recognized that systems and network biology has the potential to 
increase our understanding of how nutrition influences metabolic pathways and homeostasis, 
how this regulation is disrupted in a diet-related disease and to what extent individual 
genotypes contribute to such diseases
12
.  
Biochemical and physiologic associations among hypertension, diabetes and cardiovascular 
diseases have grown steadily, supported by basic, clinical and epidemiologic research. The 
possibilities of treating these pathologies include pharmacologic approaches, lifestyle 
adjustment and diet modification. The identification of foods that have cardiovascular health 
benefits has become a major public health objective. There is now a large body of 
epidemiologic evidence that supports the concept that diets rich in fruit and vegetables 




However, the physiologic and molecular mechanisms by which fruit and vegetables act to 
reduce the risk of vascular disease remain elusive
14
.  
The existence of data showing that the health benefits of fruit and vegetables are causally 
linked to their flavonoid content, is a starting point from which mechanistic uncertainties can 
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Cacao, tea, grapes and grapefruit are examples of edible plants that are rich in flavanols. 
Translational research that relates the consumption of these foods to cardiovascular health is 
of particular interest 
16
. Numerous epidemiologic studies support the concept that regular 
consumption of foods and beverages rich in antioxidant vitamins and flavonoids is associated 
with a decreased risk of CVD mortality
17
. Foods that have been identified as having a high 
polyphenolic flavonoid content include many fruits and vegetables such as apples and onions, 
teas (green and black), red wines and specific types of chocolate
18,19,20,21
. 
1.4 New era “omics” 
The exponential growth of technological sciences in recent decades has led researchers to 
have an increasing number of investigative techniques, such as gene cloning, the genome and 
proteome sequencing, methods of gene expression analysis, optimization of electrophoretic 
separation techniques and the evolution of mass spectrometry. These investigative techniques 
have provided researchers with the tools for large scale studies and in this context the concept 
"-omics" was born
7
. “Omics” are very convenient handles for describing the holistic 
approach for looking at complex systems and it is a general term for a broad discipline of 
science and engineering concerned with analyzing the interactions of biological molecular 
components in various ‘omes’
22
. 
The development of these ‘omics’ has depended on, and has also been driven by, advances in 
chromatography and electrophoresis, as well as highly sensitive and specific analytical 
techniques to permit the handling of large numbers of samples with high selectivity and 
sensitivity. The classical methods of molecular biology (Northern blot analysis, polymerase 
chain reaction in real time, in situ hybridization, etc..) have the enormous limitation of being 
able to quantify the expression of only one or a few genes at one and the same time. The 
sequencing of the genome has opened the way to new avenues of research including the study 
of the expression of all genes of a cell at the transcriptional and translational level and the 
analysis of interactions among all proteins. The development and design of novel stationary 
phases for selective enrichment and separation is one of the key points for establishing a 
successfully running ‘omics’ platform
23,24
. Technologies of genomics, transcriptomics, 
proteomics, metabolomics and other-omics have the potential to provide an overview of the 
pathogenesis of complex diseases, especially if they are applied with an approach for the 
integration of different technologies. Genomics deals with the genetic mapping and 
sequencing of entire genomes (structural genomics) and seeks to understand the ways in 
which the genes that make up our genome direct the development and functioning of our 
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bodies and how their failure induces a pathological state (functional genomics). 
Transcriptomics is concerned with the transcriptome, the set of transcripts, in particular 
mRNA, which carry the information for protein synthesis. With the sequencing of the 
genome, biology has made great strides to understand the complexity of an organism from 
the point of view of the content of its information and as often happens in the scientific 
world, the information obtained immediately demonstrates that there are limits
25,26
.  
The huge amount of information contained in the genome, provides a list of proteins that can 
be expressed by the genome, but does not provide any information about the proteins that are 
actually expressed or made active at a given time or cellular compartment. Moreover the 
knowledge of the nucleotide sequence of a gene does not allow the prediction of the possible 
post-translational modifications that may occur following protein synthesis. Even an 
approach based only on the analysis of messenger RNA, does not indicate the presence and 
levels of protein expression, as there is a linear correlation between amount of mRNA and 
protein quantity
27
. The axiom of biologists "one gene = one protein" has now been overcome 
by a reality which is much more complex. The proteins represent the results of transduction 
and therefore their study is the key step to a realistic understanding of the biological events at 
the molecular level. Currently proteomics is one of the most fruitful technologies of post-
genomic research, essential for highlighting the role of proteins expressed in a tissue and the 




The term proteome was introduced by Wilkins et al. (1996) to identify proteins (pro-) 
expressed by a genome (-oma)
29
. Proteomics is the discipline that seeks to catalog the 
proteins of an organism (proteome) determining the sequence and analyzing the overall set of 
proteins in different cell types at different stages of development and in different 
pathophysiological stages (fig. 2).  
At present, proteome means all proteins expressed by a genome, from a tissue, or a cell type, 
at a particular moment of the life of the cell and as such can be seen as the end product of the 
genome in a given moment of cellular life
30

























Figure 2. A common workflow in a proteomic experiment. Protein samples can be derived from tissues, plasma, 
cultured cells. Proteins are digested (1) and the resulting peptide (peptide mass fingerprint-PMF) are separated 
by chromatography (2), ionized (3) and the mass-to-charge ratio (m/z) is measured (4). To identify the amino 
acid sequence, peptides are selected for fragmentation and subjected to MMS/MS (5). Finally, bioinformatics 
tools are used to identified the proteins in the samples (6).  Modified by A. F. Maarten Altelaar et al.34. 
 
In fact, while the genome remains constant inside the cell, the protein level is complex, where 
biological mechanisms may undergo many variations such as glycosylations, 
phosphorylations, etc. which are further linked to factors associated to time, physiological or 
pathological conditions, reproductive status, growth or death. The identification and 
sequencing of all the proteins of a cell are much more complex than mapping and sequencing 
a genome. If genomics on the one hand can help in the identification of mutations effecting 
phenotypic traits, proteomics can shed light on the protein kit of some post-translational 
modifications. There are in fact many potential variability factors between a gene and its 
corresponding finished product, the protein. These include deletions, amplifications and 
modifications, co-splicing and post-translational modifications. All this underlines the 
importance of the study of the proteome as a real science and as such in recent years it has 
been considered equal to the study of the genome. The challenge of proteomics goes well 
beyond that posed by functional genomics, being that for 30,000 genes there are about 




Proteomics can be divided into expression proteomics, which allows for a quantitative study 
of protein expression between different samples; structural proteomics, whose main objective 
is to map the entire cellular proteome; and functional proteomics, which in time includes the 
study of the interactions between proteins (interattomica), the study of the interactions 
between a protein and its substrates (metabolomics) and the study of specific functions of the 















protein (enzyme genomics, genomics biochemistry). Proteomics is the comprehensive 
approach for the comparative analysis of the whole proteomic profile and large-scale protein 
expressed by a cell, tissue or organism under certain environmental conditions. Proteomics 
takes advantage of the combination of different technological analyses both, biochemical and 
computational, allowing for one to simultaneously study thousands of proteins which, when 
taken together, can decipher the structure, interpret the interactions and analyze the function. 
Therefore the purpose of proteomics is not only to identify all cellular proteins and their 
function, but also to create a map of the cell, in which is indicated the localization of each 
protein. Proteomics is the indispensable complement to genomics and, in an attempt to 
overcome the limitations related to the static nature of the genome, addresses the difficulties 
related to the enormous variety and variability of a set of proteins that are constantly 
changing in response to any type of and intra-extra-cellular event. For now, the main 
approach of clinical proteomics is directed at diagnosis and the identification of new 
biomarkers, but may in the future identify new therapeutic targets, new drugs and new 
vaccines, to improve the treatment and prevention of numerous diseases. Making use of 
advanced technologies such as mass spectrometry (Mass Spectrometry MS) is currently 
possible to determine which post-translational modifications were made, information to date 
which is poorly represented in the literature
33,34,35,36
. 













Figure 3. Schematic principle of two-dimensional electrophoresis. Modified by Rabilloud et al.30. 
 
The 2D analysis is a technique that exploits the double separation of complex mixtures of 
proteins. Firstly the proteins are separated by isoelctric focusing (IEF; the first dimension), 
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where they are separated on the basis of isoelectric point (pI). In this step the proteins have 
reached their pI and thus have no remaining electrical charge. Secondly the IEF-gel is then 
loaded on top of an SDS PAGE gel and the proteins are separated according to their 
molecular masses (SDS-PAGE; second dimension). The result is a map of "protein spots", 
which can be further identified and characterized. In order to make an analysis of differential 
expression, it is essential the digitization of two-dimensional maps and their comparison 
using appropriate image analysis software, which allows the detection and measurement of 
the spots on the gel after reducing the noise and removing artifacts.  
The identification of the proteins is carried out by combining the use of two-dimensional 
electrophoresis and mass spectrometry, which allows the analysis of peptides obtained by 
hydrolyzing proteins with specific proteolytic enzymes
30
.  
In the recent decades, the remarkable technological advances of mass spectrometry have 
greatly contributed to the development of proteomics, due to its ability to accurately measure 
the molecular weight, charge and determine the amino acid sequence of the protein, allowing 
for a rapid identification of proteins
28,37
. 
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2. CACAO AND CHOCOLATE 
2.1 Definition 
Cacao (Theobroma cacao L.; Sterculiaceae), referring to the unprocessed cocoa bean from 









Figure 4. Theobroma cacao pods  
 
Chocolate and cocoa are two different terms and are not interchangeable. Cocoa is the non-fat 
component of cocoa liquor (finely ground cocoa beans) which is used in the processing of 
chocolate, or as cocoa powder (commonly 12% fat) for cooking and drinks. Cocoa liquor 
contains approximately 55% cocoa butter and together this comprises cocoa solids, often 
cited on chocolate packaging. Chocolate refers to the combination of cocoa, cocoa butter, 
sugar and so forth into a solid food product
39
. A recent survey found that in Europe, 58% of 
people ate milk chocolate, closely followed by dark chocolate (43 %). For the UK, these 
figures were 61 and 35 %, respectively. In the USA, milk chocolate is also considered the 
most popular, but the majority of their confectionery consumption (87 %) is not as pure 
chocolate but rather it is embellished with nuts, wafer, fruit, etc.
40
. Cocoa taken as a beverage 
is also popular in some countries like Spain and should also be taken into account when 
surveying the intake of chocolate and cocoa products
39
.  
The consumption of cocoa products and chocolate contributes to human nutrition through 
provision of lipids, sugars, minerals (potassium, magnesium, copper and iron) and 
antioxidants, principally polyphenols. Tea and red wine have long been known for their high 
content of polyphenolic substances, but it is not well known that cocoa bean as well as cocoa 
derived products, also present a rich source of polyphenols, which exhibit an equal or even 
higher antioxidant capacity than some fruit or vegetables
41
. 
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However, questions arise as to which of these products could deliver the best polyphenol 
content and antioxidant effects. Cocoa-derived foods (cacao powders, chocolate, cocoa-
related products) are phenolic-rich foods derived from the fermented, roasted and milled 
seeds of Theobroma cacao
45
.  
These products, consumed all over the world, are largely studied because of the antioxidant 




Phenolics of cocoa (as well as those of other plant species) have been reported in many 
studies as bio-active compounds (antioxidant, antiradical, anticarcinogenic properties)
47,48,49
. 
Further, the anti-microbial properties of cocoa phenolics against some food bacterial 
pathogens have been shown. The anti-microbial activity is directly correlated to the 
penetrance of the bacterial cell wall
50
. 
The in vivo bio-activity of cocoa phenolics (as well as phenolics from other foods like coffee 




  2.2 Historical overview 
The word cacao is derived from Olmec and the subsequent Mayan languages (kakaw). The 
chocolate-related term cacahuatl is Nahuatl (Aztec language), derived from Olmec/Mayan 
etymology. The scientific name Theobroma cacao was given to the species by the Swedish 
botanist Carl Linnaeus in 1753, which he published it in his famous book Species Plantarum, 




Over the centuries, the use of cacao has evolved to what we now know as chocolate 
(processed bean in solid or liquid form containing varying percentages of cocoa liquor, cocoa 
butter, sugar and milk) and cultivation has extended globally to include the equatorial regions 
of Africa and Asia.  According to the Mayan and Mexican religions, cacao had divine origins. 
Cacao was discovered by the Gods in a mountain that also contained other delectable foods to 
be used by the Mayan. Historically speaking, cacao was viewed as magical and mystical. It 
played an important role in early meso-American cultures and had many uses ranging from a 
medication to a currency
38
.  
The medicinal use of cacao or chocolate, both as a primary remedy and as a vehicle to deliver 
other medicines, originated in the New World and diffused to Europe in the mid 1500s. These 
practices originated among the Olmec, Mayan and Mexican (Aztec) populations. Although 
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today chocolate is often viewed as a food with minimal nutritional value, from the middle of 
17th century to the 20th century, Europeans praised the dietary and healing properties of 
cacao. It was believed that chocolate “..comforted the liver, aided in digestion and made one 
happy and strong.” Additional uses for chocolate included stimulating the kidney and 
treatment of anemia, tuberculosis, fever and gout. Important for this study, during the 17
th
 
century, chocolate was also viewed as being of value for strengthening the heart and for the 
treatment of heart pain. The concept that chocolate (or the beverage cocoa) had health 
benefits was accepted throughout much of Europe until the 20th century, after which it 
tended to be viewed with a more neutral perspective. Early colonial era documents included 
instructions for the medicinal use of cacao
53
.  
Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain, 
revealed more than 100 medicinal uses for cacao/chocolate. Three consistent roles can be 
identified: 1) to treat emaciated patients to gain weight; 2) to stimulate nervous systems of 
apathetic, exhausted or feeble patients; and 3) to improve digestion and elimination where 
cacao/chocolate countered the effects of stagnant or weak stomachs, stimulated kidneys and 
improved bowel function. Additional medical complaints treated with chocolate/cacao have 
included anemia, poor appetite, mental fatigue, poor breast milk production, 
consumption/tuberculosis, fever, gout, kidney stones, reduced longevity and poor sexual 
appetite/low virility. Chocolate paste was a medium used to administer drugs and to counter 
the taste of bitter pharmacological additives. In addition to cacao beans, preparations of cacao 
bark, oil (cacao butter), leaves and flowers have been used to treat burns, bowel dysfunction, 
cuts and skin irritations
52
. 
One of the first documents to mention cacao, or chocolate, in a Western language was penned 
by Hernando Cortés in his second dispatch to the Emperor of Spain in a letter dated October 
30, 1520. The first Europeans to encounter cacao were Columbus and his crew in 1502, when 
they captured a canoe at Guanaja that contained a quantity of mysterious-looking “almonds,” 
later identified as a source of currency in Mesoamerica.  These “almonds” were cacao beans 
and Columbus remained unaware of their preparation as a beverage and of their importance 
in Mesoamerica, in fact, they were commonly used as money. In the centuries after the initial 
contact between the Spaniards and indigenous peoples of the New World, hundreds of 
descriptive accounts, monographs and treatises were published that contained information on 
the agricultural, botanical, economic, geographical, historical, medical and nutritional aspects 
of cacao/chocolate. Before initial European–Mexican contact in 1519, cacao was prepared 
only as a beverage and was a food reserved for adult males, specifically priests, highest 
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government officials, military officers, distinguished warriors and occasionally sacrificial 




Of the 22 known species of the genus Theobroma, only T. cacao is widely cultivated outside 
of its native habitat. Since the middle of 20
th
 century, T. cacao varieties have been classified 
into three groups: “Criollo”, “Forasetero” and “Trinitario”, hybrid of the two previous 
varieties. The harvest of pods occurs about twice per year. In addition to the varietal 
differences, fermentation of cocoa beans is an important step for obtaining a proper flavor 
and characteristics. The fermentation step involves some changes in the phenolic content of 
cocoa nibs: a strong decrease of total soluble phenolic content and the polymerisation of 
certain constituents, above all (-)epicatechin with one other (-)epicatechin or with 
anthocyanidins, to form high molecular weight (tannins)
54
.  
After fermentation, there is the drying phase, following which the beans are cleaned and 
roasted. Once the beans are roasted, they are crushed to obtain the grain (cocoa nibs), which 
is then sent to a mill where it is further minced and then melted at 80°C to obtain a mass, the 
described cocoa liquor. The liquor is then hot pressed, where occurs the separation of the 
cocoa butter from the dry matter, the panel, which is then broken to obtain cocoa powder. 
Free low molecular weight polyphenols still present in chocolate are responsible for the 
astringent and bitter taste. Some polyphenolic compounds are clearly involved in color 
development of T. cacao beans, as well as other molecular classes (mainly proteins and 
reducing sugars involved in Maillard reactions) that act during the fermentation step and 
during the roasting process
51
. 
The next stage is the conching where further grinding and mixing takes place at a temperature 
of 80 ° C, in which the cocoa particles reach a size of 15-20 µM and to which are added 
cocoa butter and lecithin, to get a better homogenization and optionally other ingredients 
dependent on the type of chocolate being prepared. The step of tempering is very important. 
During this operation, the product is cyclically cooled to 18-28 °C to promote the 
crystallization of cocoa butter in the more stable polymorph and finally heated to 32 °C to 
melt the less stable crystalline forms. The last phase of the production of chocolate is the 




Unfermented Forastero cocoa beans have been reported to contain 120–180 g/kg 
polyphenolic compounds.  






The total amount of soluble polyphenols in the dried fat-free mass of fresh cocoa beans is 15 
to 20% (about 6% in air dried cocoa beans which contain 54% fat and 6% water) and about 
5% in fermented beans. Wollgast and Anklam
46
 report on the change in composition and 
quantity during fermentation, drying and the manufacturing of chocolate. 
 2.4 Bioactive substances of cocoa 
Theobroma cacao L. and cocoa-derived products are phenolic-rich foods. These products are 
studied largely because of their antioxidant and antiradical in vitro properties due to their 
phenolic constituents
51
. Furthermore, cocoa can be defined as a functional food due to its 





















Figure 5. Chemical structure of the major cocoa monomeric flavanols, (-)-epicatechin and (+)-
catechin. Two or more monomeric forms are oligomeric procyanidins like procyanidin (4β8)-
dimers and procyanidin (4β6)-dimers the common procyanidins found in cocoa and cocoa products. 
 
Polyphenols in cocoa and cocoa products can be classified into three main groups: catechins 
or flavan-3-ols (about 37%), anthocyanins (about 4%; cyanidin glycosides) and 
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proanthocyanidins (about 58%) 
45,49
.  According to Kim and Keeney and co-workers
58
, the 
unfermented cocoa bean contains about 120–180 g/kg of polyphenolic compounds, with (-)-
epicatechin being quantitatively the main compound (approximately 35%)
49
. Traces of (+)-
gallocatechin, (-)-epigallocatechin, (-)-epicatechin-3-gallate
59
,  and numerous procyanidins 
19,60
, as well as small quantities of quercetin, quercetin glycosides, naringenin, luteolin, 
apigenin, clovamide and phenolic acids such as caffeic, ferulic, gallic and p-coumaric acid 
have also been found in cocoa products
61,62
.  
For cocoa, the terms that are used to describe the particular compounds of interest are 
flavanols (also known as flavan-3-ols or catechins). Flavanols are a subclass of flavonoids 
which are, in turn, a subclass of polyphenols. Flavanols can be monomeric and those found in 
cocoa beans are (-)-epicatechin and (+)-catechin (their isomers may also be present in small 
quantities), dimeric (the most common in cocoa are B2 and B5, both made of two units of 




Procyanidins (PCs) are oligomers of flavan-3-ol monomer units formed from the association 
of several monomeric units: 2–10 units in (epi)catechin oligomers and over 10 units in 
(epi)catechin polymers. The PCs differ in the position and configuration of their monomeric 
linkages, whereby C4C8 and / or C4C6 bonds are the predominant types 
57
.  
Their inclination to form complex compounds with proteins, polysaccharides and alkaloids 
enhances the complexity of cocoa products 
45,64
.   
Cooper et al.
39 
showed that epicatechin concentrations can be used to predict the content of 
other polyphenols, especially B2 and C1 and total polyphenol content.  Flavonol glycosides 
such as quercetin-3-O-arabinose, isoquercitrin,quercetin-3-O-glucuronide and quercetin have 
also been reported in cocoa samples. Another minor phenolic cocoa constituents, such as 








3.1 Polyphenols  
Polyphenols are products of the secondary metabolism of plants. This is an extremely wide 
and complex group of plant substances, which can range from simple molecules, such as 
phenolic acids, to highly polymerized compounds, such as tannins. They constitute one of the 
most numerous and ubiquitous groups of plant metabolites and are an integral part of both 
human and animal diets
66
. 
For decades, plant polyphenols have interested scientists because they are essential to plant 
physiology for their contribution to plant morphology (ie., pigmentation). They are also 
involved in growth and reproduction and provide plants with resistance to pathogens and 
predators (by acting as phytoalexins or by increasing food astringency,  thus making food 
unpalatable), they protect crops from plague and pre harvest seed germination, amongst 




As such, polyphenols, have been studied for taxonomic purposes or to determine the 
adulteration of food products. They have several industrial applications, such as in the 
production of paints, paper and cosmetics, as tanning agents and in the food industry as 
additives (natural colorants and preservatives)
66
.  
In addition, some phenolic compounds, the flavonoids, have applications as adjuvant 
therapeutic treatments and anti-inflammatory agents, as well as in the treatment of diseases 
such as hypertension, vascular fragility, allergies, hypercholesterolemia amongst numerous 
others
68
. An interest in food phenolics has greatly increased recently, due to the antioxidant 
and free radical-scavenging abilities associated with some phenolics and their potential 
effects on human health
69
. 
The chief reason for this interest is the recognition of the antioxidant properties of 
polyphenols, their great abundance in our diet and their probable role in the prevention of 
various diseases associated with oxidative stress, such as cancer and cardiovascular and 
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3.2 Chemical characteristics  
Phenolic compounds as food components are represented by more than 6000 identified 
substances, the largest group of secondary metabolites in plant foods 
57
.  
They are characterized by a large range of structures and functions, but generally possess an 
aromatic ring bearing one or more hydroxy substituents. Kroll et al.
 63 
summarized the 
structure, classification and distribution of phenols in plant foods, intake and their 
physiological effects. Polyphenols are the most abundant antioxidants in a diet and the daily 
intakes of total polyphenols may range from less than 100 mg to in excess of 2 g 
57
. 
According to Harborne et al.
71
, polyphenols can be divided into at least 10 different classes 
depending on their basic chemical structure. With regard to their structure, the major groups 
of phenolic compounds are distinguished by a number of constitutive carbon atoms in 
conjunction with the basic phenolic skeleton. The food relevant groupings include firstly, the 
hydroxybenzoic acid derivatives (HBAs) with a general structure C6-C1 (e.g. salicylic and 












Figure 6. The general structure of hydroxybenzoic acid derivatives with a general structure C6C1   
 
 
Variations in their basic structure being hydroxylations and methoxylations of the aromatic 
ring. As a general rule, HBAs are present as conjugates, although they can also be detected as 
free acids in some fruits. The main source of gallic acid is tea, particularly green tea, where it 
occurs also esterified as (–)-epigallocatechin- 3-gallate (EGCG)
72
. 
The second group are the phenolic compounds having the general formula C6-C3 
(hydroxycinnamic acid derivatives, fig. 7), representing a series of trans-phenyl-3-propenoic 
acids differing in their ring substitution. These compounds are widely distributed as 
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conjugates in plant material including many foods and beverages where the most common are 












Figure 7. The general structure of hydroxcinnamic acid derivatives with a general structure C6C3   
 
The third and the largest group are represented by the flavonoids, which can be further 











Figure 8. The structure of the flavonoids with a C6-C3-C6 flavone skeleton 
 
They are also the most widespread and diverse, with their common structure being 
diphenylpropanes (C6-C3-C6) consisting of two aromatic rings linked through three carbons 
that usually form an oxygenated heterocycle
65
. Figure 8 adapted from Bravo et al.
66
 
represents the basic structure and the system used for carbon numbering of the flavonoid 
nucleus. Flavonoids occasionally occur in plants as aglycones, although they are most 
commonly found as glycoside derivatives
66
. 
The common classes and food sources of flavonoids include: flavanols (quercetin, 
kaempferol, myricetin in onions, apples, tea and red wine), isoflavones (daidzein, genistein in 
soy), flavan-3-ols or flavanols (catechin, epicatechin in tea, chocolate, red wine), flavanones 
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(naringenin, hesperitin in citrus fruits), flavones (apigenin in celery, luteolin in red pepper) 
















Figure 9. Chemical structures of the main flavonoid families present in plants that are part of human 
diets. In the center: the basic generic flavonoid structure showing A, B, and C rings and the numbers 
for the various positions in the flavan structure. For the flavanol family, the structure of (−)-
epicatechin is shown. 
 
As a subclass of the flavonoid family, flavan-3-ols can be subdivided based upon the degree 
of polymerization, oxidative state and the substitution pattern of the B- and C-rings
74
.  
Five major monomeric flavan-3-ols, referred to as catechins, are found in the diet: (+)-
catechin (C), (−)-epicatechin (EC) (fig. 5), (-)-epigallocatechin (EGC), (−)-epicatechin gallate 
(ECG), and (−)-epigallocatechin gallate (EGCG) (fig. 10). Structurally, gallocatechins (EGC 
and EGCG) differ from catechins (C, EC, and ECG) by having a third B-ring hydroxyl group 



































Figure 10. Chemical structure of the major tea monomeric flavanols. 
 
















Figure 11. Structure of the catechin/epicatechin enantiomers 
 
(-)Epicatechin is quantitatively the main compound of cocoa phenolics (approximately 35% 
of polyphenols content of unfermented Forastero cocoa beans).  The total soluble phenolics 
of good fermented dried cocoa beans ranges from 2 to 6%, strictly depending on the variety 
as well as the geographic origin. The typical content for Forastero is about 6%, while the 
soluble phenolic content in Criollo cacao is about 2/3 of Forastero. A high content are often 
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an index of bad fermentation. In addition to monomers, more complex flavan-3-ols exist, 
including the proantocyanidins (PAs). The PAs are dimers (2 monomer residues), oligomers 
(3–7), and polymers (≥8) of flavan-3-ol monomers. Monomers are bonded by interflavan 
linkages between the C-ring of the first monomer and either the A- or C-ring of the next. 
Proanthocyanidins (PAs) are subdivided in procyanidins (PCs), prodelphinidins (PDs) e 
Propelargonidins (PGs). The PAs consisting exclusively of (epi)catechin are PCs
78,19
.  
A-type PAs have monomers joined by two interflavan linkages: the C4→C8 bond plus a 
C2→O→C7 ether bond. The B-type PAs have only one interflavan linkage (typically 
aC4→C8 or C4→C6 carbon-carbon bond) and finally the C-type condensed tannins are 




It is important to know not only a person's daily intake of dietary polyphenols but also the 
bioavailability of those ingested polyphenols, since their nutritional significance and potential 
systemic effects will greatly depend on their behavior in the digestive tract
81
. 
Only some 5% of dietary polyphenols are absorbed in the duodenum, and of this only 5%, 
mainly flavanols, reach the plasma unchanged. Over 95% of the intake passes to the colon 
and is fermented by the gut microflora
57
. 
This is not a straightforward process, with little is known about the absorption of polyphenols 
in the gastrointestinal tract, such as whether they are retained in the body after absorption and 
what their biologic significance might be
82
. 
The enormous variability of this group of substances, as well as their occurrence in plant 
materials as a complex mixture of phenolic compounds, creates great difficulties in the study 
of their bioavailability and their physiologic and nutritional effects. Direct evidence of 
bioavailability can be gained from plasma concentrations of the flavonoid or its metabolites 
and indirect evidence can be obtained from biomarkers such as plasma antioxidant capacity, 
LDL oxidation susceptibility, platelet function, vascular tone and immune responsiveness 
38,83,84,85,86
.  
The first human bioavailability trial of polyphenols from chocolate found that with 40 g of 
black chocolate, epicatechin was indeed absorbed into the blood. Epicatechin was present in 
plasma as metabolites conjugated with glucuronide and sulphate groups. These compounds 
exhibited a Tmax of 2 h in the plasma and Cmax of over 100 ng/ml
39
. 
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Chocolate (particularly dark chocolate) can be seen as a relevant source of phenolic 
antioxidants. With respect to the bioavailability of polyphenols, in particular flavanols, 
reliable data on the real content of polyphenols in food are still scarce
51
.  
Despite this, the bioavailability of flavanols (as well as all phenolics) has been discussed. For 
example, independently of the doses of chocolate and cacao ingested, only 0.5% of catechin 
was recovered in the free unbound form in the plasma and in the urine
51,49,54,87
. 
Estimates from human studies indicate that dietary flavanols, including those found in cocoa, 
display variable oral absorption, with reported values varying from less than 1 to greater than 
50 percent of the ingested dose, as cited by Rein et al
88
, Richelle et al.
44
 and Schramm et al.
89 
 
but more realistic values of the observed average absorption should be around 5%. The 
variable absorption of flavanols between subjects probably results from the complexity of the 
in vivo system, a large inter-individual variability, as well as variability between differing 
compounds such as quercetin, epicatechin and soy isoflavones. Chemical structure plays a 
large role in determining the absorption, distribution, metabolism and excretion and 
ultimately the biologic properties of these phenolic
87
. 
Significant losses of bioactive substances are also attributed to gastric pH-induced 
degradation
90
, enterocyte metabolism of flavanols, first pass metabolism and the type and 
activity of intestinal microflora
89
.  
The plasma half-life of all flavonoids is relatively short (24 hours) and consistent with this, 
plasma epicatechin concentrations typically return to baseline values within six to eight hours 
after the consumption of a flavonoid-rich chocolate meal
38
.  
Another issue to take into consideration when talking about bioavailability, is the chiral 
nature of polyphenols and the effect of chirality. For instance, the (+) form of catechin tends 
to dominate in cocoa beans and the (-) form in chocolate. Schroeter et al.
91
 found that 
chocolate tended to contain predominantly (-)-epicatechin and (-)-catechin, with only small 
amounts of (+)-catechin and negligible (+)-epicatechin. The same research indicated that the 
(+) form of catechin was almost 10 times more absorbed than the (-) form using a rat 




Flavonoids circulating in plasma, including those derived from cocoa, occur primarily as 
glucuronide, methyl and sulfate conjugates, or combinations thereof as a result of phase I and 
II enzyme action in the small intestine and liver
92
.  
Orally administered epicatechin in mammals is thought to largely undergo glucuronidation at 
the level of the intestinal mucosa
93
.  
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Thus, the rise in epicatechin in plasma observed after the proantocyanidinis-rich chocolate 
intake may be due in part to epicatechin metabolites (in particular, unmethylated glucuronide, 
glucuronide sulfate and unmethylated sulfate conjugates), as well as to free epicatechin
57,88
. 
Epicatechin is rapidly absorbed in humans. Indeed, in healthy human adults, plasma 
concentrations can approach 1umol/L within two hours after the consumption of flavonoid-
rich chocolate. Plasma epicatechin concentrations from dark chocolate are in the same range 




After absorption in the intestinal tract, (-)-epicatechin is rapidly metabolized by both 
enterocytes and hepatocytes. In both cell types, (-)-epicatechin undergoes transformation by 
uridine-50-diphosphate glucuronosyl-transferases, sulfo-transferases, and catechol-O-
methyltransferases. The net result of the extensive first-pass metabolism is the presence of 
glucuronides, sulfates, and/or  methyl conjugates in the bloodstream. The metabolic fate of (-
)-epicatechin after the ingestion of cocoa powder, chocolate and teas In humans has been 
previously investigated. The majority of those reports have analyzed (-)-epicatechin after the 
exposing the biological samples to glucuronidase or sulfatase enzymes
92
.  
Recently, Ottaviani et al.
94 
identified two main metabolites, however, they could not 
completely describe the entire conjugate forms because the analytical methodologies 
employed were semi-quantitative due to the lack of purified and isolated (-)-epicatechin 
conjugates for use as standards. Therefore, despite several investigations, the complete (-)-
epicatechin conjugates in biological samples are still unclear and it will be a crucial step in 
elucidating the molecular mechanism of action
92
. 
Experiments reported in the literature have used extracts of different plant materials that 
contain a mixture of soluble phenolic compounds or pure standards used as supplements in 
complex foods administered either to laboratory animals or human volunteers. When plant 
extracts are used, it is possible to gain information on the effect of their constituent 
polyphenols as a group, but not on the digestive fate and specific effects of individual 
polyphenols. Conversely, differences in the absorption, metabolism and physiologic effects 
of food phenolics administered as supplements, compared with polyphenols that are part of a 




Bioavailability can also be affected by the matrix in which the cocoa polyphenols are 
delivered. It is possible that different matrices affect the release of polyphenols from food, 
making them more or less available for absorption
39
. 
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This is a question that is often asked when considering health effects: dark or milk chocolate? 
Many countries around the world predominantly consume cocoa as part of milk chocolate 
rather than dark. The polyphenols in chocolate come from the cocoa liquor. Hence, as milk 
chocolate generally contains less cocoa liquor than dark chocolate, it will contain less 
polyphenols. White chocolate contains no cocoa liquor and hence no polyphenols at all. 
However, this is complicated by the fact that polyphenols can be destroyed during the 
processing of the raw cocoa depending on the manufacturing methods used. The 
concentration of flavanols in any chocolate depends on both the flavanol content of the cacao 
plant and the procedures used for transforming the cocoa into chocolate
16
.  
Interestingly, Serafini et al. 95 demonstrated an increase in total antioxidant capacity and 
plasma epicatechin concentrations after consumption of dark chocolate (100 g) in 12 healthy 
volunteers; however, these effects were reduced by the presence of milk. It was also shown 
that the absorption of epicatechin from chocolate was significantly less when consumed with 
milk or as milk chocolate. Thus, the hypothesis is that milk proteins bind to cocoa 
polyphenols, which in turn prevents their absorption in the gastrointestinal tract. However, 
this study generated much controversy in the literature. Schroeter et al.
96 
reported that the 
presence of milk in cocoa products did not influence the absorption or biological activity of 
epicatechin from the cocoa product. Matrix effects are becoming increasingly important for 
food due to a new EU legislation Directive 2000/13/EC that came into effect in January 2007 
which makes it essential that any food labeling a high content of a beneficial compound must 
be able to demonstrate that it is bioavailable from that food product and has its implied 
beneficial effect. However, it is felt that this issue with respect to chocolate, has not been 
resolved, as there has been no definitive study confirming the bioavailability with solid milk 




All of these limitations represent difficulties to overcome in studying the bioavailability of 
polyphenolic compounds and their nutritional significance and as such caution in interpreting 
results is necessary. Both in vivo and in vitro studies using polyphenolic compounds with 
different chemical structures and solubility illustrate varying susceptibility to digestion, 
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3.4 Polyphenols effect 





,  neurodegenerative diseases
99
, diabetes and osteoporosis
100
.  
However, it is very difficult to predict from these results the effects of polyphenol intake on 
disease prevention in humans
65
.  
Firstly, estimation of dietary intake of polyphenols is difficult, due to limited availability of 
food composition data and the inherent bias of dietary assessment methods, thus identifying a 
need for good biomarkers
101
.  
Secondly, most of the observed physiological effects are based on either in vitro models, 
cell/tissue culture studies, animal experiments or epidemiological data. The results thus 
obtained are generally projected to show if a strong association or correlation of activity in 
humans is possible or not, since data from human investigations are relatively rare. Thirdly, 
these studies have often been conducted at doses or concentrations far beyond those 
documented in humans. More human studies are therefore needed to provide clear evidence 




Recent human studies have proven that chocolate has beneficial effects on some pathogenic 
mechanisms of heart disease such as endothelial function and blood pressure
38,102
.  
Flavanol-rich foods can positively affect hemostasis, through mechanisms that either directly 
affect platelet function or increase certain endothelium-derived factors that maintain platelet 
acquiescence or increase fibrinolysis. Holt et al.
103
 found that after the consumption of 25 g 
chocolate, supplying 220 mg flavanols and procyanidins, there was a decrease in primary 
hemostasis, measured by the time to occlude an aperture in a collagen membrane, being 
observed 2 h after consumption. Further, Murphy et al.
104 
demonstrated that an acute dose of 
flavanols and oligomeric procyanidins from cocoa powder inhibits platelet activation and 
function over 6 h in humans. The inverse association of a high fruit and vegetable intake with 
the risk of CVD mortality in numerous epidemiologic studies has led to many hypotheses 
regarding the physiologic role of flavonoids. Cocoa, tea and wine are increasingly viewed as 
sources of dietary components with potentially beneficial functional activities. It should be 
noted, however, that there are no epidemiologic studies specifically evaluating the 
relationship of chocolate intake and CVD risk. The chemical structure of flavonoids suggests 
that they have antioxidant capacity, with the ability to scavenge free radicals and chelate 
redox active metal ions. It has been postulated that these bioactive compounds can contribute 
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to the maintenance of the integrated  network of cellular and plasma oxidant defense 
mechanisms, to vascular wall tone and to a reduction in platelet reactivity with a subsequent 
reduction in the risk of clot formation. The key to determining the physiologic significance of 
dietary flavonoids is to develop an understanding of their metabolism and mechanisms of 
action
105
. In the past 10 years, there has been increased interest in the potential health-related 
benefits of antioxidant- and phytochemical-rich dark chocolate and cocoa
106
.  
It has been becoming clear that there is a relationship between the effect of antioxidants in a 
diet and immune functions. Recently it was suggested that chocolate contains large amounts 
of polyphenols that have antioxidant activities
48
. All polyphenols exert an antioxidant action 
in vitro; however, this does not mean that all polyphenols have an antioxidant effect in vivo
45
. 
It is apparent in most of the studies, which examined the antioxidant properties of chocolate 
or cocoa beverage, that the major cocoa flavanol, epicatechin, is readily absorbed and peaks 
in the plasma concentration at 2 hours. The antioxidant properties of cocoa or chocolate 
consumption are associated with an increase in plasma epicatechin concentrations
69
.  
The flavan-3-ols have been identified as the major antioxidant components of different cocoa 
ingredients and chocolate preparations. Oxygen radical absorbance capacity (ORAC) data 
show that chocolate, as a whole food, has a potent antioxidant capacity when compared with 
other phytochemical-rich foods such as garlic, blueberries and strawberries
38
. 
Commercial chocolate products were found to decrease lipid oxidation when added to LDL 
preparations in vitro. That the amount of epicatechin absorbed from a dose of chocolate can 
be physiologically important is suggested by the observation that significant increases in 
plasma antioxidant capacity and decreases in plasma lipid oxidation products, correlate with 
the changes in plasma epicatechin concentrations. Examination of the literature regarding 
CVD risk reduction and plasma antioxidant effects of catechins from dietary sources other 
than chocolate reveals mixed results, but, overall, a trend toward beneficial health effects is 
apparent. A recent meta-analysis of epidemiologic studies on tea consumption concluded that 
3 cups a day may reduce the population incidence rate of myocardial infarction
107
. 
Comparison of individual clinical trials must take into account variations in design, methods, 
and outcome measures of the studies. For example, two studies reported that consumption of 
six cups of green or black tea, or a green tea infusion containing about 400 mg of catechin, 
resulted in a significant increase in the total plasma antioxidant capacity in humans. In 
contrast to this, consumption of green or black tea was not shown to increase the resistance of 
LDL to ex vivo oxidation, despite observations that tea catechins significantly increased LDL 
resistance when added to the assay in vitro
38
.  
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The antioxidant properties of cocoa were largely studied in recent years by means of different 
approaches: chemical characterization of involved antioxidant species (HPLC, HPLC-MS)
108
, 
in vitro chemical studies (in order to study the ability to scavenging some stable radicals like 
DPPH, ABTS+), in vitro biological studies and nutrigenomic-based studies (bioavailability, 
in vivo interaction with cellular/molecular species)
109,26 
. 
Some bio-active properties of cocoa are strictly related to phenolic content as well as to some 
compounds from the Maillard reactions (non-enzymatic brown pigments)
51
.  
In conclusion, the citation: “It is yet to early to give an answer to the question, whether 
chocolate and / or other sources rich in catechins and procyanidins are beneficial to human 
health and thereby becoming functional in their nature”, still explains the current status. 
Factors like food matrix (e.g. consumption of milk at the same time as dark chocolate reduce 
the bioavailability of polyphenols) still need to be considered
46
. 
3.5 Bioactive action of cocoa polyphenols 
It is an appealing idea that a food commonly consumed for pure pleasure could also bring 
tangible benefits for health. Cocoa is rich in polyphenols, similar to those found in green tea, 
and as polyphenols have been shown to have beneficial effects on CVD, it has resulted in 
heart health being the most common target for research on cocoa
39
.  Richelle et al.
44
 first 
demonstrated the appearance of epicatechin in blood after consumption of black (dark) 
chocolate and 3 years later a study demonstrated the presence of a dimer in the plasma within 
30 min post-consumption of flavanol-rich cocoa. Many researchers have investigated the 
kinetics and extent of polyphenol absorption by measuring plasma concentrations and/or 
urinary excretion among adults after the ingestion of a single dose of polyphenol, provided as 
pure compound, plant extract, or whole food/beverage. Manach and co-workers
110
 reviewed 
97 studies of various classes of polyphenols. They have compiled the data from the most 
relevant studies, those using well-described polyphenol sources and accurate methods of 
analysis, to calculate mean values for several bioavailability measures, including the maximal 
plasma concentration (Cmax), time to reach Cmax, area under the plasma concentration-time 
curve, elimination half-life, and relative urinary excretion. The results clearly showed wide 
variability in the bioavailability of the different polyphenols and the metabolites present in 
blood, resulting from digestive and hepatic activity, usually differ from the native 
compounds. Cocoa polyphenols have been reported in many studies as bioactive compounds, 
with antioxidant, antiradical and anticarcinogenic properties
111
. Oligomeric procyanidins 
isolated from cocoa have been shown to possess biological activities potentially relevant to 
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oxidant defences and immune function
112
. Further, it is well-known that methylxanthines 
have physiological effects on various body systems, including the central nervous, 
cardiovascular, gastrointestinal, respiratory and renal systems
45
. Flavanols are attractive 
candidates for natural and alternative medicine due to their high abundance in green tea, red 
wine, cocoa and chocolates. Interestingly, it was found that a relatively small community of 
Kuna Indians residing in a Panamanian archipelago exhibit low blood pressure and a reduced 
incidence of cardiovascular disease and stroke. After a comprehensive assessment of genetic 
and environmental factors, epidemiological studies concluded that these health benefits may 
result not necessarily from genetic predisposition but likely from a high intake of cocoa 
extract that was found to be especially enriched in flavanols
113
. The research is predominantly 
focused on effects on the vascular system: however, there are other areas of research on man 
in vivo which are not so extensively investigated, such as those concerned with cognition, 
cancer, diabetes and inflammation. Multiple approaches have been used to investigate the 




3.5.1 Anti-hypertensive effect  
Hypertension is a well-established risk factor for the development and acceleration of 
atherosclerosis. Oxidative stress and the inactivation of NO by vascular superoxide anion 
(O2
•−
) play critical roles in the pathogenesis of vascular disease, including hypertension
101
. 
Gómez-Guzmán et al. 
114 
studied the effects of chronic treatment with epicatechin on blood 
pressure, endothelial function and oxidative status in deoxycorticosterone acetate (DOCA)-





. The high dose of epicatechin prevented both the increase in systolic blood 
pressure and the proteinuria induced by DOCA-salt. They found that epicatechin increased 
the transcription of nuclear factor-E2-related factor-2 (Nrf2) and Nrf2 target genes in aortas 
from control rats and also improved the impaired endothelium-dependent relaxation response 
to acetylcholine and increased the phosphorylation of both Akt and eNOS in aortic rings
115
.  
In the recent years, regarding the great interest about this topic, many meta-analyses have 
been published. Hooper and co-worker
116
 performed a meta-analysis, a total of 1637 
potentially relevant titles and abstracts were identified from searches on Medline, EMBASE, 
and the Cochrane Library, together with other reference sources and information provided by 
relevant experts. Ninety-eight articles were collected as full text and assessed for inclusion, 
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and 42 acute and short-term chronic studies were identified as being randomize controlled 
trials (RCTs) of chocolate, cocoa, or cocoa flavan-3-ols. 
They observed a reductions in diastolic blood pressure and mean arterial pressure after cocoa 
chronic intake but no effects on systolic blood pressure. Their results suggest that epicatechin 
dose may be a key contributor to the effects observed. Doses of >50 mg epicatechin/d 
reduced systolic and diastolic blood pressure, whereas doses <50 mg/d did not. These 
findings support that an oral administration of pure (-)-epicatechin mimics acute vascular 
effects of flavan-3-ol–rich cocoa. This suggests that lower-dose studies may dilute the “true” 
response of chocolate or cocoa, thus reducing the apparent effectiveness within meta-
analyses. 
The identification of healthy foods and the understanding of how food components influence 
normal physiology will help to improve the health of the population. This could be especially 
relevant with regard to untreated pathologic states
16
. Several open-label studies described by 
Egan et al.
115 
reported that dark chocolate lowered blood pressure among volunteers with a 
wide range of ages and baseline blood pressure values. In the 13 reports, dark chocolate 
lowered BP in 6 of 7 open-label studies but diastolic BP only in 1 of 6 double-blind studies. 
Collectively, these reports raise questions on the BP-lowering efficacy of dark 
chocolate/cocoa, including the possibility that BP effects are negligible. These studies 
suggest that dark chocolate could be useful for the prevention and management of 
hypertension in a broad segment of the population. However, the published studies on 
chocolate and blood pressure include a relatively small number of subjects, with conflicting 
result, such that a clear answer on the antihypertensive effects of dark chocolate may not yet 
be given. 
3.5.2 Effect on lipid oxidation 
Intervention trials and prospective studies have shown that hypercholesterolemia, especially 
increased concentrations of LDL cholesterol, leads to the development of atherosclerosis. 
Epicatechin, the major polyphenol in chocolate and chocolate extracts, is a powerful inhibitor 
of plasma lipid oxidation due to polyphenols ability to bind to lower density lipoproteins
38
. 
There is also evidence that oxidized LDL has a pathogenic role in the development of 
atherosclerosis. Uptake of oxidized LDL by macrophages and smooth muscle cells leads to 
the formation of fatty streaks, a key event in early atherosclerosis
85
. Waterhouse and 
colleagues
117 
wrote a letter, which was published in 1996, that described an in vitro 
experiment that was to open up a whole new area for nutrition and health. Polyphenols were 
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extracted from commercial cocoa and chocolate, with the polyphenol content and antioxidant 
activity against LDL oxidation assessed. They found a potent inhibition by the cocoa 
polyphenols. At 5mmol/L total polyphenols (expressed as gallic acid equivalents), LDL 
oxidation was inhibited by 75 %, compared to red wine at 37–65 %. This was the first 
publication to state that the action and content of polyphenols from cocoa meant that it could 
be considered as a dietary source of antioxidants
39
. Studies carried out in healthy human 
subjects also showed a decrease in LDL cholesterol concentrations, increases in HDL 
cholesterol concentrations and a resistance of LDL to oxidation following the intake of dairy 
cocoa powder. An example is the study conducted by Baba et al.
85
 where they evaluated 
plasma LDL cholesterol and oxidized LDL concentrations following the intake of different 
levels of cocoa powder (13, 19.5, and 26 g/d) in normocholesterolemic and mildly 
hypercholesterolemic humans. In their comparative, double-blind study, 160 subjects who 
ingested either cocoa powder containing low-polyphenolic compounds (placebo-cocoa group) 
or 3 levels of cocoa powder containing high-polyphenolic compounds (13, 19.5, and 26 g/d 
for low-, middle-, and high-cocoa groups, respectively) for 4 wk. A stratified analysis was 
performed on 131 subjects who had a LDL cholesterol concentrations of ≥ 3.23 mmol/L at 
baseline. In these subjects, plasma LDL cholesterol, oxidized LDL, and apo B concentrations 
decreased, and the plasma HDL cholesterol concentration increased, relative to baseline in all 
the cocoa groups. The results suggest that polyphenolic substances derived from cocoa 
powder may contribute to a reduction in LDL cholesterol, an elevation in HDL cholesterol, 
and the suppression of oxidized LDL. However, this finding was not stable to sensitivity 
analysis in which lower-quality studies were removed or in which data from different study 
durations were used. 
3.5.3 Effects on glucose metabolism and insulin resistance 
Numerous studies indicate that polyphenol-rich chocolate reduces fasting blood glucose, 
blood pressure and total cholesterol in healthy and hypertensive individuals, with or without 
glucose intolerance. Grassi and co-worker
118
 reported that the consumption of dark chocolate 
improves glucose metabolism and decreases blood pressure. They studied 15 healthy young 
adults with typical Italian diets that were supplemented daily with 100 g dark chocolate or 90 
g white chocolate, each of which provided 480 kcal. The authors found that the dark 
chocolate supplement was associated with decreased insulin resistance and increased insulin 
sensitivity. 
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In another study published by Almoosawi et al.
119
 they demonstrated that polyphenol-rich 
dark chocolate reduces fasting blood glucose levels and blood pressure in overweight and 
obese individuals. Moreover Hopper and co-worker
116
, mentioned in the section 3.5.1 above, 
in the same meta-analysis suggested significant reductions in fasting serum insulin 
concentrations, serum insulin after glucose challenge after chocolate or cocoa interventions. 
Their results support the reciprocal relation between insulin resistance and endothelial 
function and suggest that the effect of cocoa/chocolate interventions on fasting insulin 
concentrations may be associated with endothelial function as suggested by significant 
studies on insulin and vascular diseases or VCAM regulation
120,121
. These data are further 
supported by in vitro studies showing effects of flavan-3-ols and their metabolites on glucose 




 3.5.4 Effect on the inflammatory system 
During the past years, a growing number of studies, mostly conducted in vitro or ex vivo, 
have demonstrated that flavanols share the capacity to modulate inflammation as well as 
other major metabolic and immunological pathway. It has been suggested that cocoa-derived 
flavonoids may affect the production of pro-inflammatory mediators. In general, flavonoids 
are often considered as potential anti-inflammatory molecules. However, in some studies, 
procyanidins, as present in cocoa, partly increased the production of tumor necrosis factor 
alpha and NF-kB  dependent pro-inflammatory gene expression. Among the myriad of health 
promoting effects suspected for antioxidants, anti-inflammatory actions seem to be 
promising. In fact, flavanols inhibit lipid peroxidation and affect production of lipid or lipid-
derived molecules regulating the immune response and, recently, dietary cacao has been 
shown to ameliorate obesity-related inflammation in high fat-fed mice
122
. Data from 
numerous studies suggest that cocoa-derived flavanols can effectively modify the 
inflammatory process
45
. It has been observed that cocoa products influence specifically 
endothelium-derived NO synthesis and metabolism, cytokine production and eicosanoid 
metabolism through a specific action on peripheral blood mononuclear cells (PBMC)
123
.  
Furthermore, preliminary in vitro investigations have suggested that cocoa flavanols or 






 demonstrated that cacao liquor polyphenols inhibit reactive oxygen species 
and reduce the expression of interleukin 4-2 mRNA in human lymphocytes. Polyphenols 
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from other plant sources also inhibit the cellular expression of IL-8 and monocyte 
chemoattractant-1 when induced by the proinflammatory cytokine tumor necrosis factor-α 
Several clinical studies have shown improved endothelial function after cocoa consumption, 
but it is not known if these improvements are due to a subtle combination of mild effects 
rather than a single targeted effect
39
.  
Dietary intervention trials investigating the effect of flavonoids on markers of inflammation 
in human subjects are scarce and are focused on a limited number of foods of plant origin 
such as black and green teas, fruit juices, grape extract and red wine
212
. The experimental 
evidence in human subjects suggests a direct role for plant foods in modulating the 
inflammatory response in vivo. However, the mechanism and the molecules responsible for 
this effect have not been identified
126
.  Murphy et al.
104 
showed an effect on P-selectin plasma 
levels together with an increase of plasma catechins after 4 weeks of cocoa tablet 
administration. Widlansky et al.
127 
observed, in patients with coronary artery disease, an 
increase in plasma catechin concentrations after 4 weeks of daily ingestion of 900 ml black 
tea, without any effect on CRP. Steptoe et al.
128 
showed a reduction in CRP levels after 6 
weeks of black tea consumption, however, no evidence was provided regarding the extent of 
flavonoid absorption. Studies with alternative sources of dietary flavonoids such as grape 
juice and red wine were also contradictory. Watzl et al.
129 
showed that both acute and chronic 
administration of red wine, de-alcoholized red wine and red grape juice had no effect on 
cytokine production, phagocytic activity of neutrophils and monocytes, lymphocyte 
proliferation and lytic activity of natural killer cells
130
. However, Estruch and co-workers
131 
found reduced plasma levels of fibrinogen, IL-1α, CRP, vascular cell adhesion molecule-1 
and intercellular adhesion molecule-1 and an increase in plasma levels of epigallocatechin, 
after 4 weeks of red wine consumption. Although existing evidence indicates that flavonoids 
potentially display a multitargeting anti-inflammatory action, a clear conclusion on their 
effects in human subjects cannot be drawn
212
. 
3.5.5 Effect on endothelium 
Cocoa polyphenols have been investigated predominantly for their effect on the vascular 
system, with NO concentrations being a central target. One of these effects is on endothelial 
function, which is an extremely promising biomarker to calculate heart attack risk
45
.  
NO is produced from L-arginine in a reaction catalyzed by the enzyme nitric oxide synthase 
(NOS). This enzyme is present in mammals in different isoforms: endothelial (eNOS), 
neuronal (nNOS), inducible (iNOS), which is expressed in response to different stimuli as 
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well as mitochondrial NOS (mtNOS). NO reacts with several metal centers, molecular 
oxygen, thiol groups and some oxygen radicals
80
.  
The beneficial cardiovascular effects of flavonoids are attributed to their ability to improve 
endothelial function, by activation of the NO synthase system. In particular cocoa 
polyphenols may activate endothelial nitric oxide synthase (eNOS) thereby increasing the 
concentration of vasodilative nitric oxide. L-arginine is the substrate of eNOS and arginase 
competes with eNOS for L-arginine as the common substrate. Thus, the concentration of this 
aminoacid  is an important determinant for cellular NO production by eNOS
132,133
.  
It is hypothesized that the potential beneficial effects of chocolate on vascular health are at 
least partly mediated by cocoa polyphenols including procyanidins. Based on cell culture 
studies, molecular targets of chocolate polyphenols are endothelial nitric oxide synthetase as 
well as arginase
69
. There is also some evidence suggesting that platelet aggregation may be 
modulated through a flavan-3-ols. Platelet function is related to the risk of developing 
atherothrombosis, the principal cause of heart attack and stroke. Indeed, activated blood 
platelets play a central role in this chronic inflammatory condition as they are major 
components of thrombi that occlude arteries
134
.  
Platelet function can be affected by various dietary components, including a wide range of 
plant-based products, however, the mechanisms by which those compounds affect platelet 
function are not yet fully understood 
135
.  
The experimental evidence for beneficial vascular effects of chocolate in human interventions 
studies is yet not fully convincing. Some human intervention studies on chocolate and its 
polyphenols lack a stringent study design. They are sometimes underpowered and are not 
always placebo controlled. Dietary chocolate intake in many of these human studies was up 
to 100 g per day. Since chocolate is a rich source of sugar and saturated fat, it is questionable 




 3.5.6 Other effects 
Gut microbiota plays a key role in host physiology and metabolism. Indeed, the relevance of 
a well-balanced gut microbiota composition to an individual´s health status is essential for the 
person's well-being. The percentage of polyphenol absorption is very low and as much as 
90% of these compounds persist into the colon. There, they are metabolized via esterase, 
glucosidase, demethylation, dehydroxylation and decarboxylation activities of bacteria, 
resulting in smaller metabolites, some of which can be absorbed across the intestinal 





. Hayek et al.
138 
has recently revisited data showing that cacao and/or chocolate 
modifies intestinal flora in the same way that prebiotics and probiotics do. As the functional 
interactions between gut microbiota and host metabolism are indeed shown in several studies 
and result in health maintenance, some of the benefits of cacao may be due to this indirect 
mechanism. Potential health-promoting benefits of flavanols in cacao require more 
experimental effort. 
 
3.6 Other bioactive substances of cocoa 
 
Although most of the studies indicate that the health benefits of cocoa or cocoa products are 
attributable to polyphenols, it should be noted that cocoa and cocoa products are not only rich 
in polyphenols, but are also rich in xanthines, which account for about 3.2% of defatted 
unsweetened chocolate composition. Xanthines are a variety of compounds produced by 
plants and animals that have not been studied as frequently as other substances of 
metabolism, such as ATP or GTP. The active compounds in cacao that are structurally similar 
to xanthine are methylxanthines, of which the action on human physiology is quite 
remarkable. The main methylxanthines of cocoa are theobromine (3.7% on a fat-free basis) 
and caffeine (about 0.2%). The possible synergistic interactions between flavonoids and 
methylxanthines are also unclear and need further study, so the contribution of theobromine 
in cocoa products towards health benefits should be considered
139
. 
It is clear that the cocoa flavonoids represent an exciting new area of nutritional research with 
significant implications for cardiovascular protection. Further experimental studies with 
cocoa flavonoids are needed to define the specific mechanisms of action. Furthermore, the 
plasma concentration of chocolate polyphenols is relatively low, often in the nanomolar 
range, and the flavonoid concentrations, as used in cultured cells, may sometimes be higher 
than physiological levels. In addition to epicatechin, cocoa appears to be an important source 
of other dietary polyphenols, including proanthocyanidins and quercetin. Until now, the 
antioxidant capacity of cocoa has been attributed only to the epicatechin content. However, 
other compounds might also be important contributors to the total polyphenols present in 
cocoa and convey potential health benefits. It is clear that cocoa is a complex plant food that, 
in its finished products may well contain sufficient amounts of these interesting 
phytochemical antioxidants to favorably influence in vivo oxidant defense. Data as described 
herein in the present thesis, may support this hypothesis.  
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4. INFLAMMATION AND DIET 
4.1 Inflammation: a new perspective 
Inflammation is a normal biological process in response to tissue injury, microbial pathogen 
infection and chemical irritation. This biological process also involves the innate and 
adaptive immune systems. At a damaged site, inflammation is initiated by migration of 
immune cells from blood vessels and release of mediators, followed by recruitment of 
inflammatory cells and release of reactive oxygen species (ROS), reactive nitrogen species 




Thus, the main function of inflammation is beneficial for a host’s defense. In general, normal 
inflammation is rapid and self-limiting, but aberrant resolution and prolonged inflammation 
causes various chronic disorders. In this respect, in recent years an idea has been developing 
that chronic inflammation can inflict more serious damage to a host tissue than bacterial 
infections. Inflammatory chemicals produced by inflamed and immune cells also attack 
normal tissues surrounding the infected tissue, causing oxidative damage and extensive tissue 
inflammation. Studies show that chronic inflammation is linked to a wide range of 
progressive diseases, including cancer, neurological disease, metabolic disorder and 
cardiovascular disease. This suggests that the elimination of chronic inflammation is a major 
way to prevent various chronic diseases
48
. Immune cells, especially macrophages, are crucial 
for directing the host's foreign body reactions and producing various proinflammatory 
mediators
141
. It has long been recognized that macrophages produce oxygen- and nitrogen-
reactive metabolites during phagocytosis or when stimulated by a variety of agents
142
.  
ROS such as superoxide anion (O2 −) are widely investigated as signaling mediators of both 
protection and destruction in macrophages
143
.  
Diverse Reactiv Oxygen Species and Reactive Nitrogen Species such as O2 (superoxide 
anion), OH (hydroxyl radical), H2O2 (hydrogen peroxide), nitric oxide (NO) and 
1
O2 (singlet 
oxygen) generated by inflammatory cells, injure cellular biomolecules including nucleic 




The majority of dietary antioxidants are derived from the intake of vegetables, fruits, tea and 
wine. Epidemiological studies provide convincing evidence that natural dietary compounds 
consumed by humans as food, possess many biological activities. Among these natural 
bioactive compounds, flavonoids are widely recognized for their biological and 
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pharmacological effects, including antiviral, anti-carcinogenic, antioxidant, antimicrobial, 




4.2 Oxidative stress  
For the past 40 years, oxidative stress has been increasingly recognized as a contributing 
factor in aging and in various pathophysiologies which are generally associated with aging
144
. 
The term ‘‘oxidative stress’’ began to be used frequently in the 1970s, but its conceptual 
origins can be traced back to the 1950s to researchers pondering the toxic effects of ionizing 
radiation, free radicals and the similar toxic effects of molecular oxygen 
145
, and the potential 
contribution of such processes to the phenomenon of aging
144
.  ROSs are constantly produced 
in aerobic organisms as by-products of normal oxygen metabolism and include free radicals 
such as superoxide anion (O2
-
) and hydroxyl radical (OH
-




At low concentrations, ROSs serve as an important second messenger in cell signaling, both 
for endogenous and exogenous reactions/pathways. However, at higher concentrations and 
long-term exposure, ROSs can damage cellular macromolecules such as DNA, proteins and 
lipids, which leads to necrosis and apoptotic cell death
147
.  
ROSs are natural by-products of metabolism and these molecules play important roles in cell 
signaling, but excessive levels of ROSs can be toxic to cells
148
.  
Much of the research on ROSs has been centered on the damaging effects of oxidative stress. 
However, it is now apparent that ROSs activate a battery of cellular enzymes that either 
prevent the generation of ROSs or detoxify ROSs and thereby protect the cell against damage 
caused by oxidative stress
147
, including superoxide dismutases (SODs), heme oxygenase-1 
(HO-1), NAD(P)H quinine oxidoreductase-1 (NQO-1), catalase and thioredoxin. However, 
they are not sufficient to control ROSs and minimize ROS-induced damage. A compromised 
anti-oxidant defense system can lead to excessive oxidative stress and ultimately result in cell 
damage
146
. Therefore, it is clear that all cells must continuously strive to keep the levels of 
ROSs in check. ROSs attack DNA and other cellular macromolecules causing oxidative 
stress and many other physiological and pathological conditions. These conditions include 
aging, neurodegenerative diseases, arthritis, arteriosclerosis, inflammatory responses and 
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The acceptance of free radical biology was remarkably slow, probably due to the largely 
theoretical and hypothetical nature of its beginnings, the evanescent nature of free radicals, 




4.3 Implication of oxidative stress in diseases 
There has been a recent explosion of interest in the notion that chronic low grade 
inflammation and activation of the innate immune system are closely involved in the 
pathogenesis of type 2 diabetes. It was demonstrated that markers of inflammation predict 
and/or are associated with type 2 diabetes and that inflammation is involved in the 
pathogenesis of atherosclerosis, a common feature of type 2 diabetes
140,151
. 
Obesity is regarded as a hyper-oxidative and chronic inflammatory status, the significant 
interrelationships among obesity-related indices, oxidative stress, inflammatory markers and 
adipokines have been well documented
152
. 
It is reported by Furukawa et al., that in cultured adipocytes, increased oxidative stress may 
cause deregulated production of adipokines, including leptin, adiponectin, PAI-1 and 
monocyte chemotactic protein-1 (MCP-1) thus lead to metabolic derangements
153
.  
Antioxidant components are microconstituents present in the diet that can delay or inhibit 
lipid oxidation, by inhibiting the initiation or propagation of oxidizing chain reactions, and 
are also involved in scavenging free radicals. Food such as fruits, vegetables and grains are 
reported to contain a wide variety of antioxidant components, including phenolic compounds, 
such as polyphenols. These compounds are found to be well correlated with antioxidant 
potential. As previously described, cocoa beans have a high phenolic content and these 
compounds were reported to be a potential candidate to combat free radicals, which are 
harmful to our body and food systems
48
.  
In vitro studies demonstrated that these compounds have several biological activities, such as 
the ability to scavenge superoxide radicals and hydroxyl radicals, reduce lipid peroxyl 




4.4 NRF2 pathway 
4.4.1 The transcriptional factor: NRF2 
The cellular defense system protects against oxidative stress caused by a vast range of 
xenobiotics, inflammation and ionizing radiation
154
. 
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Therefore, it is obvious that cells must constantly labor to control levels of ROSs, preventing 
them from accumulating. Cells have mechanisms to activate over two hundred defensive 








Figure 12. Schematic representation of NRF2 domains. 
 
In the early 1990s, the antioxidant response element (ARE) was first identified as cis-element 
in the upstream regulatory region of the GSTA2 gene and was found in the promoters of 
detoxifying enzyme genes such as glutathione S-transferases, NAD(P)H:quinine 
oxidoreductases, gastrointestinal glutathione peroxidase and peroxiredoxin
154
.  
As more and more AREs were identified, it became apparent that the ARE sequences of 
different genes, and even of the same gene from different species, varied significantly. John 
Hayes and colleagues have carefully compared AREs and categorized them into four 
classes
155
. ARE is recognized by the family of Cap’n’Collar containing basic leucine zipper 
proteins including Nrf2 (fig. 12). The NF-E2-related factor-2 (Nrf2) is a transcription factor 
that is ubiquitously expressed at low levels in all human organs. It was cloned independently 
in 1996 by Kant and coworkers and it was identified as a regulator of the expression of the 
beta-globin genes, and as such was named Nrf2
156
.  
It belongs to the cap ‘n’ collar (CNC) subfamily,  a family of basic leucine zipper 
transcription factors conserved in worms, insects, fish, birds and mammals, including 
humans, but absent in plants and fungi. They are defined by the presence of a conserved 43 
amino acid CNC domain located N-terminally to the DNA binding domain
157
.   
In spite of the high homology in their DNA binding and leucine zipper domains, six members 
in this family have been identified: NF-F2, Nrf1, Nrf2, Nrf3, Bach1, and Bach2 each with 
distinct biological roles. NF-E2 expression is erythroid-specific-1, Nrf1, is expressed in all 
tissues with its absence lethal effecting embryonic development. Nrf2 is also ubiquitously 




Several homologue domains were identified when Nrf2 from different species, such as 
human, mouse and chicken, were aligned. They are designated as Neh 1–6 (NRF2-ECH 
                                                                                                                                                Introduction 
45 
 
homology: Neh). The Neh1 domain contains a CNC-type basic leucine zipper, which is 
necessary for DNA binding, dimerization with other transcription and it is also a functional 
nuclear localization signal (NLS)
160
.  
The N-terminal Neh2 domain contains seven lysine residues for ubiquitin conjugation, so it 
confers negative regulation of the Nrf2 activity through proteasome-mediated degradation of 
Nrf2
155
.  It also binds to the Kelch domain of Keap1
161
. The Neh4 and Neh5 are two 




The function of Neh6 remains largely unknown, although it is known to have a high content 
of serine residues. The C-terminal Neh3 is indispensable for transcriptional activity of Nrf2 




 Among the family, Nrf2 is the most potent transcription factor in regulating the basal and 
inducible expression of antioxidant enzyme genes
154
.  
The most convincing data demonstrating that Nrf2 is a critical regulator of AREs came from 
Tom Kensler’s laboratory. This group showed that Nrf2-knockout mice had reduced levels 
and impaired induction of detoxifying enzymes and redox balancing proteins, rendering the 
knockout mice more susceptible to carcinogen-induced cancers.  Nrf2 has emerged as the 
master regulator of a cellular defense mechanism that elicits an adaptive response and 









, identified Keap1 (fig. 13), kelch-like ECH-associated 








Figure 13. Schematic representation of KEAP1 domains. 
 




































This protein is essential for the regulation of activity of NRF2. Keap1 exist as dimers inside 
the cell with the complex consisting of two Keap1 molecules and one Nrf2 molecule. These 
proteins interact with each other through the double glycine-rich domain ok keap1 and the 
hydrophilic region in the neh2 domain of NRF2
164
. Under normal conditions, Nrf2 resides 
within the cytoplasm of the cells interacting with an actin-bound cytosolic protein, Keap1, 
being constantly degraded via ubiquitin-proteasome pathway in a keap1-dependent 
manner
165
. The inhibitor Keap1 is a cysteine-rich protein with human Keap1 containing 27 
cysteine residues with C257, C273, C288, C297 and C151 acting as sensors of oxidative 
stress. Moreover Keap1 functions as a substrate adaptor protein for a Cullin 3, (Cul3)-
dependent ubiquitin-protein ligase, complex to maintain the steady-state levels of Nrf2. 
Covalent conjugation of proteins by ubiquitin usually involve three enzymatic activities for 
activating (E1), conjugating (E2), and ligating (E3) ubiquitin to a substrate. Keap1 constantly 
targets Nrf2 for ubiquitination and subsequent degradation by the 26S proteasome. Under 
induced conditions, the activity of the Keap1-Cul3 E3 ligase is inhibited due to modification 
of cysteine residues in Keap1, resulting in stabilization of Nrf2 and activation of the Nrf2 
pathway. However the precise mechanism by which the modification of cysteine residues in 






















Figure 14. The Keap1–Nrf2 pathway. 
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When a cell encounters stress, Nrf2 dissociates from Keap1 and translocates into the nucleus 
(fig. 14). Oxidative/electrophilic stress induced modification of keap1-Cysteine151 results in 
the release of NRF2 from the inhibitor. In addition, to disrupt the binding between NRF2 and 
its repressor, there is another step control: the phosphorylation of NRF2 at Serine (S40) and 
at threonine residues by kinases such as phosphatidylinositol 3-kinase (PI3K), protein kinase 
C (PKC), c-Jun NH2-terminal kinase (JNK) and extracellular-signal-regulated kinase (ERK) 
or transmembrane protein kinase PERK
165,167,168
. 
Nrf2 is stabilized and translocates into the nucleus, where it heterodimerizes with small Maf, 
Jun or yet unknown proteins and in turn binds to the ARE that leads to the coordinated the 
activation of a myriad of genes that protect cells against oxidative/electrophilic stress and 
neoplasia such as phase II detoxifying enzymes and antioxidant-responsive genes
169,170
. 
In addition to these mechanisms, Nrf2 appears to be an important regulator of the peripheral 
inflammatory responses and thus may also contribute to the neuro-inflammatory component 
of ischemic brain injury
171
. 
The abundance of Nrf2 inside the nucleus is tightly regulated by positive and negative factors 
that control nuclear import, binding to ARE, export and degradation of Nrf2. A delayed 
response of oxidative/electrophilic stress activates GSK-3β that phosphorylates Fyn at 
unknown threonine residue(s). Phosphorylated Fyn translocates to the nucleus and 




The degradation of Nrf2, both in the cytosol and nuclear compartments, rapidly brings down 
its levels to normal resulting in suppression of Nrf2 downstream gene expression. An auto-
regulatory loop between Nrf2 and keap1 controls their cellular abundance. Nrf2 regulates 
keap1 by controlling its transcription, and keap1 controls Nrf2 by degrading it. In conclusion, 
switching on and off of Nrf2 combined with promoting an auto-regulatory loop between them 
regulates activation/ deactivation of defensive genes leading to protection of cells against 
adverse effects of oxidative and electrophilic stress thus promoting cell survival
154
. 
4.4.4 NRF2 and diseases 
Indeed, accumulating evidence has been provided recently indicating a protective role of 








For this reason, many researchers have focused on identifying potent Nrf2 inducers with low 
toxicity to enhance the Nrf2- mediated adaptive response for disease prevention. For 
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example, human clinical trials, pioneered by Tom Kensler 
176
, were conducted to evaluate the 
efficacies of Nrf2 inducers such as oltipraz and broccoli sprouts. Mechanistic studies indicate 
that the chemopreventive activities of Nrf2 inducers lie in their ability to modulate 
absorption, distribution, metabolism and excretion of carcinogens, as well as the anti-
inflammatory response. As chronic inflammation has been recognized as a risk factor for 
cancer development, the anti-inflammatory activity of Nrf2 is considered a contributing 
factor to its role in chemoprevention. Paradoxically, the role of Nrf2 in cancer promotion and 
in cancer resistance to therapeutic treatment, the negative side of Nrf2, has recently been 
revealed. Constitutive up-regulation of Nrf2 is associated with many types of cancers, 
including skin, breast, prostate, lung, neck and endometrium
177,178
. 
Studies using Nrf2 deficient mice have demonstrated that this transcription factor regulates 
immune cell responsiveness, prostanoids, cytokines and chemokines expression in response 
to various insults. For example, mice deficient in Nrf2 showed up-regulated gene expression 
of pro-inflammatory cytokines, interferon-inducible transcripts and nuclear factor kappa B 
(NFκB)-binding activity in peritoneal macrophages after administration of bacterial 
endotoxin or lipopolysaccharide
179
. A wide variety of dietary polyphenols and other classes 
of phytochemicals have been reported to induce the expression of enzymes involved in both 
cellular antioxidant defenses and elimination/inactivation of electrophilic carcinogens. 
Induction of such cytoprotective enzymes by edible phytochemicals is recognized as one of 
the highly effective strategies for preventing cancer in the human population
180
.  
Detailed investigations into the specific dietary components of these foods have revealed that 
many polyphenolic constituents exert anti-oxidant effects on key substrates involved in the 
pathogenesis and progression of ischemic injury. These data have perpetuated the belief that 
the protective effects of flavonoids result from direct anti-oxidant actions and the 
transcriptional factor NRF2 has emerged as a critical regulator of flavonoid-mediated 
protection through the induction of various cytoprotective genes
181
. 
For example the oxidation of Keap1 cysteine thiols can be mediated by some edible 
polyphenols. In this context, it is noticeable that among flavonoids, the higher their intrinsic 
potential to generate oxidative stress and redox cycling, the stronger their potency as inducers 
of ARE-mediated gene expression
168
.  
For instance, the green tea polyphenol (–)-epigallocatechin gallate (EGCG) was found to 
produce substantial amount of H2O2 under cell culture conditions. Therefore, it is paradoxical 
that the activation of NRF2-ARE signaling by antioxidant polyphenols to induce 
cytoprotective enzymes is attributable, at least in part, to their prooxidant activity
168,182
. 





 reported that exposure of HepG2 cells to green tea polyphenols stimulates 
transcription of phase II enzymes through ARE pathway, which seems to be regulated by 
MAPK. During extensive screening of vegetable extracts for GST-inducing activity in 
cultured rat liver epithelial RL-34 cells, Morimitsu
184
 and colleagues have identified a 
sulphoraphane analogue, 6-methylsulphinylhexyl isothiocyanate (6-HITC), as a key GST-
inducer present in Japanese horseradish, wasabi. The compound potently stimulating nuclear 
translocation of NRF2 and subsequent activation of ARE pathway. In another study, 
Dinkova-kostova et al.
164 
provides evidence that sulphoraphane directly reacts with critical 
cycteine residues oh KEAP1 stoichiometrically and in 2003 Dikinson et al. 
186
 showed that 
curcumin increased nuclear translocation of NRF2. 
Several nutrients and non-nutritive phytochemicals are being evaluated in intervention trials 
for their potential as cancer chemopreventive, anti-inflammatory agents. Despite significant 
advances in our understanding of multistage oxididative stress little is known about the 
mechanism of action of most antioxidant agents. The antioxidant effects that most dietary 





























 5. AIMS OF THE STUDY I 
Diet is one of the key lifestyle factors involved in the genesis, prevention and control of many 
pathologies. Dietary components such as polyphenols present in cocoa (Theobroma cacao L.), 
show important functional properties. The polyphenolic profile of cocoa is well described 
within the literature, including monomeric and polymeric polyphenols, which show antioxidant 
and anti-inflammatory capacities. Chocolate consumption (particularly dark chocolate, as 
shown in many in vivo recent studies), triggers a positive influence on human health, as well 
elucidated in the introduction. Monocytes are key to the inflammatory status and offer an 
important model to investigate the role of dietary components and their metabolites. 
Thus, the aim of this research was to study the proteomic profile of human circulating 
monocytes, before and after dark/white chocolate administration, through a proteomic 
approach, to figure out whether an interaction between the flavonoids found in diet and the 
human circulating monocytes is possible. 
In particular a bioavailability on (-)-epicatechin (and its glucuronide metabolite) was performed 
by liquid chromatography-mass spectrometry (LC-MS) in the plasma of five healthy 
volunteers, before and after chocolate administration. Cocoa was administered in the form of 
chocolate bars with and without flavonoids (dark vs white chocolate), characterized for their 
chemical composition. Human circulating monocytes were isolated from the blood, before and 
after the administration of chocolate bars at the peak of metabolites as indicated by the 
bioavailability study. Cells were lysed and analyzed by 2D-electrophoresis with IPG strips pH 
5-8, with the respective proteomic profiles compared using PDQuest statistical software.  
The data obtained from the bioavailability experiments and proteomic analyses represent the 
initial phase of a translational ongoing study that will contribute to understanding how 
chocolate flavonoids act on inflammation and what biomarkers could be used in future clinical 
studies.  




5.1 MATERIALS AND METHODS 
5.1.1 Characterization of chocolate bar  
All dark chocolate bars used to carry out the experiments came from a single batch of Nigerian 
chocolate containing 80% cocoa and produced by a leading company in the field. The sample 
of white chocolate, used as a control, was produced by a Piedmont chocolate lab. 
The overall composition was analyzed directly using the chocolate bars, where moisture, total 
protein, lipids and ash levels were determined. The moisture content, determined in order to 
express the results on a dry weight (dw) basis, was obtained using an oven at 103 ° C (until 
constant weight). The total nitrogen content and total protein content (conversion factor: 6,25) 
were obtained according to the Kjeldahl method, using Kjeltec system I (Foss Tecator AB, 
Höganäs, Sweden). The ash content was determined in a muffle furnace according to the 
AOAC (1990) procedure. The quantification of lipid component in the samples was performed 
by continuous extraction in semiautomatic Soxhlet (BUCHI EXTRACTION SYSTEM B-811) 
using dichloromethane (Sigma-Aldrich) as the solvent. The defatted powder was subsequently 
used to obtain chocolate phenolic extract used for subsequent quantifications. Total phenol was 
determination by the classic Folin-Ciocalteu assay, using the protocol described by Arlorio et 
al.
187
. Results were expressed as catechin equivalents, through the calibration curve of (±)-
catechin monohydrate. Using the Vanillin assay described by Travaglia et al.
188
 the total 
proanthocyanidins were measured and expressed as catechin equivalents, like the previous 
analysis. The DPPH radical scavenging assay was performed according to the method reported 
by Locatelli et al.
189
. This analysis was conducted to verify the antiradical activity of the 
chocolate phenolic fraction; the results, expressed as DPPH radical inhibition percentage, are 
referred to 200 µg/µL of extract. For the identification and quantification of polyphenolic 
compounds a chromatographic method (reversed phase HPLC) was optimized. The qualitative 
identification of the major polyphenols (and eventual co-extracted methylxanthines) in the 
extracts was obtained by comparison with the retention times and the UV spectra of the 
individual standard molecules. The identified compounds were quantified by interpolation on 
the corresponding calibration lines. The analysis of the white chocolate are in process. White 
chocolate was used as a control because it contains the same ingredients as dark chocolate but 































5.1.2 Study design 
The study was approved by the Local Ethical Committee. The participants, five healthy normal 
weight young volunteers (age, mean±SD: 29.2±3.4 years; BMI: 22.1±1.0 Kg/m
2
),  followed a 
cocoa washout period before each intervention, were instructed to abstain from alcoholic 
beverages and any polyphenol-rich foods 48 hours before the study. The same diet indications 
were followed during the testing sessions. Subjects underwent two sub-studies: 1) 
bioavailability study; 2) monocytes study.  
Bioavailability study. Firstly, a blood sampling was carried out before and after eating dark 
chocolate, every hour for 4 hours following administration (daily administration). Secondly, 
the volunteers were subjected to a weekly study, in which it was taken a sample of blood 
before and 4 hours following administration of dark chocolate for seven consecutive days. 
Monocytes study. Monocytes study was designed after the bioavailability analysis. After an 
overnight fasting for at least 12 h, all subjects randomly underwent the following interventions: 
i) fasting (B); ii) assumption of 70g of dark chocolate bars (DC), iii) assumption of 70 g of 
white chocolate bars (WC), and iv) assumption of 70 g/day of DC for a week.  
Subsequently to all the interventions were performed the collection of blood, firstly, for the 
bioavailability study and secondly, understood the correct timing, the collection of blood has 









Figure 15. Schematic representation of the study design 




5.1.3 Sample preparation and LC-MS/MS Conditions  
Plasma samples were obtained following the centrifugation of whole blood and stored at -80 ° 
C until analysis. The plasma samples were purified and concentrated by the use of cartridges 
suitable for the removal of phospholipids (Phenomex i-Phree).  
Following the precipitation of plasma proteins, each sample and the internal standard IS 4-
metil-umbelliferil-β-D-glucuronide (UG, 22 µg/L in acetonitrile), were analyzed by LC-ESI-
MS, as described below, SRM mode by monitoring the transitions: 351175 for the IS and in 
MRM mode 465175 / 465289  for the (-)-epicatechin-3’-O-glucuronide (Ec-G2). The 
objective was to identify the metabolites in the plasma and, according to the results obtained, to 
plan the time to perform the withdrawals of blood samples for the isolation of monocytes and 
the study of the protein profile. To date, no other epicatechin metabolites have been 
investigated. 
5.1.4 Catechin (C) and Epicatechin (Ec) incubation with human liver microsomes 
(HLM) 
The incubation mixture was constituted with 2 mM UDPGA in a TRIS•HCl buffer, (50 mM, 
pH 7.4), containing 5 μl of methanol (1% of total volume) and C or Ec (0.5 mM), brought to a 
final volume of 0.5 ml. After pre-equilibration of the mixture at 37 °C, an appropriate volume 
of microsomal suspension, previously activated by alamethicin (50 μg/mg protein) at 4 °C for 
15 min, was added to give a final protein concentration of 1.5 mg/ml. The incubation was 
shaken for 60 minutes at 37 °C. A control incubation was carried out in the absence of 
UDPGA. Each incubation was stopped by addition of 500 µl ice-cold acetonitrile, vortexed and 
centrifuged at 12,500 rpm for 10 min. The supernatants were directly analyzed by LC-ESI-MS. 
5.1.5 LC-ESI-MS analyses 
A Thermo Finningan LCQ Deca XP plus system equipped with a quaternary pump, a Surveyor 
AS autosampler, and a vacuum degasser was used for LC/MS analyses (Thermo Electron 
Corporation, Waltham, MA). All chromatographic separations were performed on a Kinetex 
C18 (100 x2.1 mm; 2.6 μm d.p.) core-shell column (kept at a 40 °C) preceded by a 0.5 µm 
KrudKatcher depth filter (Phenomenex srl, Castel Bolognese, Italy). Aliquots (10 μL) of 
supernatants obtained from incubations were injected into the system and eluted with a mobile 
phase (flow rate 0.2 mL/min) consisting of A: 0.2% aqueous formic acid solution, B: methanol. 




The following gradient program was used: 0 min [B=15%], 7.00 min [B=30%], 7.50 min 
[B=85%], 9.00 min [B=85%], 9.50 min [B=15%], and 14.00 min [B=15%]. 
The eluants were filtered through a 0.45-μm pore size polyvinylidene difluoride membrane 
filter before use. The eluate was injected into the electrospray ion source (ESI) and an MS 
spectra was acquired and processed using Xcalibur® software. The operating conditions on the 
ion trap mass spectrometer were as follows: spray voltage, 3.30 kV; source current, 80 µA; 
capillary temperature, 300 °C; capillary voltage, -34.00 V; tube lens offset, -35.00 V; multipole 
1 offset, 10.50 V; multipole 2 offset, 14.00 V; sheath gas flow (N2), 50 Auxiliary Units. Data 
were acquired in negative full-scan, product ion scan (MS2) and single reaction monitoring 
(SRM) modes using mass scan range m/z 150-550. The collision energy was optimized to a 
range of 28-32%. 
5.1.6 Isolation of human monocytes 
Human monocytes were isolated from heparinized venous blood (30–40 mL) of the same 
healthy donors before and after administration of chocolate bars. The samples were taken at the 
time point where metabolites were identified LC-ESI-MS in plasma with the highest peak of (-
)-epicatechin-3’-β-D-glucuronide (EC-3’-G) used as the marker
91
. The isolation was carried out 
via the standard technique of dextran sedimentation with a Hystopaque (density = 1.077 g/cm
3
) 
gradient centrifugation (400×g, 30 min, room temperature), as described by Cermak and 
coworkers
190
. Cells were re-suspended in RPMI 1640 medium, supplemented with 10 mM 
Hepes, 2 mM of L-glutammine and 100 U/mL of penicillin and streptomycin (Sigma-Aldrich). 
Purified monocytes populations were obtained by adhesion (60 min, 37 °C, 5% CO2), followed 
which fresh medium supplemented with 5% heat-inactivated fetal bovine serum (FBS). Cell 
viability was determined by trypan blue exclusion, which was generally > 98% (data not 
shown). 
5.1.7 Preparation of plasma extract 
As described by Koga and co-workers
191
, plasma samples were collected prior to and following 
the administration of the same quantity of dark and white chocolate. A total of 10 mL of pooled 
plasma was mixed with 40 mL of acetone containing 1% acetic acid. The mixture was shaken 
continuously at 4 °C for 2 h and then centrifuged for 30 min at 5000 xg at 4 °C. The 
supernatant fluid was separated from the precipitate and evaporated in a rotary evaporator. The 
remaining water phase was further lyophilized. The residue was washed 2 times with 10 mL 
chloroform, dried under nitrogen gas and dissolved in 1 mL dimethylsulfoxide (DMSO):water 




(1:9 v/v). The plasma extracts were stored at - 80 °C until the LC-MS/MS analysis and in vitro 
treatment of human monocytes. 
5.1.8 Two dimensional gel electrophoresis (2-DE) 
Following the isolation of monocytes, total protein was immediately extracted
192
 and the 
protein samples diluted in rehydration solution (350 uL final volume) containing 7 M urea, 2 M 
Thiourea, 4% CHAPS, 120 mM dithiothreitol (DTT), 40 mM Tris-HCl and 2% ampholyte pH 
3-10 (Sigma-Aldrich).  
Duplicate gels were run for each sample and conditions. For the first dimension of 2-DE 
(isoelectric focusing, IEF), immobilized pH gradient strips (IPGs) pH 5-8 (Bio-Rad, Hercule, 
CA) where run using protean IEF cell system (Bio-Rad). At completion, the strips were then 
equilibrated twice for 15 min with gentle shaking in the equilibration buffer containing DTT 
and second buffer containing iodoacetamide. The second dimension was performed by 
applying the equilibrated strips (IPGs) to a 12% polyacrylamide SDS-gel (7 cm). Following 
electrophoresis, the proteins were fixed in 10% (v/v) methanol and 7% (v/v) acetic acid and 
stained with Sybro Ruby total protein Stain (Bio-Rad). The stained 2-DE gels were digitized 
using using a ChemiDoc Imager with a 615-645 nM filter (630BP30; Bio-Rad). The 
bioinformatic analysis was performed with PDQuest software (version 8.0; Bio-Rad). 
5.1.9 Gel analysis  
The analysis of protein spots on the gels was performed with the statistical software PDQuest. 
All RAW data files of scanned gel were opened with PDQuest, with all images cropped to the 
same size and aligned to include only the resolving area of the gels, excluding for this purpose 
the dye front. Each image was analyzed with the PDQuest spot detection software to identify 
valid spots. Errors of omission and commission were corrected manually on each gel after a 
careful visual inspection of the gel images magnified on the computer monitor. Replicates of 
each experimental condition were compared to a master gel, which represents the spots that 
were reproducibly present. The gels for various conditions were compared to find differences 
in spot intensity that resulted from treatment. Spots identified by PDQuest as differentially 
expressed were also examined manually to ensure that the analysis was correctly carried out. 
To compensate for any variation in protein loading and development level of Sybro Ruby, 
spots quantities were normalized based on the total staining density of the image. Differences 
between groups and treatment were compared using Student’s t-test, p values set to <0.05 were 
considered statistical significant. 




5.1.10 In-gel trypsin digestion 
The two-dimensional gels were stained overnight with Bio-Safe Coomassie G-250 Stain and 
after washes the protein spots of interest were excised manually. The gel pieces were then 
destained with destaining buffer (100 mM ammonium bicarbonate in 50% acetonitrile) prior to 
reduction with 10 mM DTT in 0,1 M ammonium bicarbonate and alkylation with 55 mM 
iodoacetamide in 0,1 mM ammonium bicarbonate. The gel pieces were dried and a modified 
porcine trypsin (sequencing grade; Promega, Madison, WI) was add to a final concentration of 
20ug/mL  with the digestion performed at 37 °C overnight. The reaction was stopped by adding 
0.1% trifluoroacetic acid (TFA) followed by washing in extraction buffer (50% acetonitrile, 
5% TFA in water). Following a centrifugation at maximum speed, the samples were dried in a 
SpeedVac and resuspended in 0,05% of TFA in water and stored at -80 °C until further use. 
The analyzes were conducted using an LC-MS (Thermo Scientific) system that includes a 
chromatographic pump for mass spectrometry (Surveyor MS Pump Plus) with an autosampler 
for the injection of samples (Surveyor Autosampler Plus), all connected to a mass spectrometer 
LTQ linear ion trap equipped with an ESI source that ionizes in positive polarity. The samples 
are injected into the system and separated by means of a chromatographic column for reverse 
phase HPLC (Zorbax SB-CN 2.1x150x5). 
The proteins were identified by comparing the masses of their tryptic peptides with those of all 
known proteins and the MASCOT database (www.matrixscience.com). 
5.1.11 Western Immunoblotting 
To confirm the proteomic results, two protein spots were analyzed by western immunoblot. 
The analysis was performed directly on the bidimensional gel (12% SDS-PAGE) and 
transferred to Immuno-Blot PVDF membrane (Bio-Rad Loboratories, Inc). The membrane was 
blocked with 5% Blotting-Grade Blocker (nonfat milk; Bio-Rad Laboratories, Inc) in TBST 
(0.1% Tween-20 in TBS) for 1 h at 37 °C. Thereafter, the membranes were incubated at 4 °C 
with mouse monoclonal anti-Rho GDP-dissociation inhibitors (Ly-GDI E-7; sc-374525) or 
mouse monoclonal anti-macrophage capping protein (CapG D-5; sc-365472)(Santa Cruz 
Biotechnology, CA) at a concentration of 1:500 in TBST. After an overnight incubation and 
subsequent washes, the membranes were incubated with the appropriate horseradish peroxidase 
(HRP)-conjugated secondary antibody at 1:5000 in TBST for 1 h at 37 °C. Immunoreactive 
protein spots were visualized by the enhanced chemiluminescence (ECL) detection system 




(Pierce Biotechnology; Rockford, IL) according to the manufacturer’s instructions and images 
were  detected using the Quantity One 1D image analysis software program.  




  5.2 RESULTS  
5.2.1 Characterization of chocolate bars 
The tests to evaluate the composition of cocoa and its derivatives were carried out as described 
in materials and methods, section I. The results of these analyses are reported in table 1.  
5.2.2 Identification of (-)-epicatechin metabolites (EC-G2) in human plasma  
Because of the lack of a commercially available EC glucuronide standard, we identified these 
metabolites by incubating EC with human liver microsomes (HLM) in the presence of the 
UDPGA cofactor. The LC-MS chromatograms of the incubation samples revealed both the 
presence of the EC m/z 289 and two peaks m/z 465 EC-G1 (Rt= 3.71 min) and EC-G2 (Rt= 
6,35 min), showing the same fragmentation pathways of the EC glucuronides reported in the 
literature (fig. 16, 17). 
Due to the relative abundance of the EC-G2 metabolite with respect to EC-G1, in accordance 
with the finding of Goretta and co-workers
92
, we can speculate the metabolite EC-G2, 
corresponds to epicatechin-3'-O-glucuronide, being that this metabolite is the EC glucuronide 
described the most in the literature. 
The plasma samples collected after the intake of chocolate, were analyzed by LC-MS 
monitoring the ion at m/z 465 corresponding to the epicatechin-3’-O- glucuronide, the most 
described EC metabolite
92
. Plasma samples were purified and concentrated by protein 
precipitation using acetonitrile as the precipitating agent, followed by phospholipid removal 
using Phenomenex Phree® phospholipid removal cartridges. Samples were injected into LC-
MS system and analyzed in negative multi reaction monitoring (MRM) mode. 4-metil-
umbelliferil-β-D-glucuronide (UG) was added as an internal standard. The chromatograms 
depicted in figure 18, show the presence of the peak labeled as EC-G2  (Rt = 6.4 min, m/z 465) 
in the samples T1-T4 and its absence in T0 traces. All the results performed after a weekly dark 
chocolate administration show the same results of the daily consumption, but after a week was 
not detected an accumulation of epicatechin (data not shown). For all analyses performed on 
plasma following the administration of white chocolate, the EC-G2 peak is absent (fig. 19) 
5.2.3 Protein expression profile in monocytes before and after chocolate 
consumption 
According to the previous results on the bioavailability, blood samples for the monocyte 
isolation, were taken from healthy donors at baseline (T0) and 3 hours after the consumption of 




dark chocolate containing 80% cocoa (T3 dark) or white chocolate (T3 white).The proteins 
were extracted from the isolated monocytes and duplicate 2D gels were run for T0 and T3 dark 
and white. After a careful visual inspection to remove background interference including 
bubbles or Sybro Ruby speackles from the gel images, an average of 746±52 protein spots 
were detected on each gel by PDQuest software. The density for each spot was normalized 
against the total spot quantity of valid spots on each gel. A representative example of the 
typical 2-D gel profile of monocytes is shown in figure 20.  
A 2D analysis in the pH range 5 to 8 was chosen in order to have a higher resolution and as 
such a clearer separation of protein spots. A total of 131±17 (P< 0.05) protein spots were found 
to be significantly different between the two groups, with 69 of these spots having a 
significance of P<0.01. Only 11 significant protein spots were chosen for further analysis 
(Table 2), because the remaining 58 protein spots had a lower intensity and were not visible 
with coomassie staining, necessary for the subsequent cutting and isolation of the spots. 
As delineated by the colored rectangles, there are a clusters of spots, which appear to have an 
alteration/modification of their intensity, with respect to the baseline profile. Representative gel 
images for each cluster of spots are shown in figure 21 .  
Regarding cluster A (fig. 22), there are only one protein spot, SSP1106 (p<0.01), which is 
expressed exclusively after the administration of dark chocolate. This protein was chosen for 
further analysis. The remaining three spots are present in all conditions, in particular spot 
SSP1104 which appears to be more highly expressed after white chocolate consumption. 
Nine spots were included in cluster B (fig. 23). As observed in the image and in the table, there 
are less abundant spots, SSP3104 and SSP3105, which are each expressed after dark chocolate 
administration.  
Cluster C (fig. 24) includes 5 protein spots, which are absent following white chocolate 
consumption but present in the other two conditions. In particular the SSP4808 and 4809 
(p<0.05) are observed only after the administration of dark chocolate, while the other two, 
while present at baseline, are less expressed. 
Cluster D (fig. 25), comprised of 3 spots, is the only example of irreproducibility of the spot 
profile between subjects, with a variability in the expression of one of the 2 spots, SSP5403 
and SSP5401 (p<0.05). Understanding this irreproducibility is a limitation of the proteomic 
technique, however possible explanations for this variability could be due to post-translational 
modifications, the absence or presence of a specific isoform of proteins or a change in the 
amino acid charge. 
 




5.2.4 Peptide Mass Fingerprint 
Selected protein spots (table 3) showing a differential expression, were excised from the gels, 
and following an in situ digestion with trypsin, the resulting peptide mass fingerprint (PMF) 
was determined by mass spectrometry performed by Dr Donatella Caruso, Department of 
Pharmacology, University of Milan. The data obtained from the mass were subjected to 
proteomic investigation program on-line MASCOT. The results showed a score greater than or 
equal to 56 are statistically significant (p<0.05). The analysis by mass spectrometry identified 
MED19 (Mediator of RNA polymerase II transcription subunit 19; A0JLT2; table 3a), RM34 
(Belongs to the ribosomal protein L34P family; table 3 a). KIF2a (Kinesin-like protein; 
O00139; table 3 d), NRL (Transcription factor which regulates the expression of several rod-
specific genes; table 3 e), PAGE3 (Belongs to the GAGE family; table 3 e) and H1FNT 
(Testis-specific H1 histone; Q75WM6; table 3 e). While the results remain to be confirmed, 
they have not led to the identification of proteins of interest for the present study. 
 
5.2.5 Identification and confirmation of RHO-GDP-dissociation inhibitor and 
macrophage-capping protein with specific antibodies 
To further confirm the proteomic results, different protein spots were analyzed by 2D 
immunoblots. Amongst the spots predicted to show an hypothetical alteration in expression 
between T0 and T3 dark and white, were SSP5403 and 5401 in cluster D which showed 
intersubject variability,y and the SSP1106 in cluster A, observed only after the administration 
of dark chocolate.   
According to the results published by Jin and co-workers
193
, the first antibody tested was 
directed to the protein Rho GDP-dissociation inhibitors (P52566) . The antibody recognized a 
protein of 5.0 pI and 23-27 KDa in monocytes after dark chocolate consumption, but was not 
detected at baseline or after the administration of white chocolate (fig. 26). These results are in 
accordance with a review published by Loirand et al.
194
 where they suggest that the activators 
of Rho proteins, Rho GEFs expressed in cardiovascular cells, are potential targets for the 
treatment of cardiovascular disorders. Since Rho GDP-dissociation inhibitors, negatively 
regulate the Rho family of GTPases, it is possible that its expression is regulated by bioactive 
substances such as polyphenols present in dark chocolate.  
The other two proteins (SSP 5401 and SSP 5403) with the same molecular weight but different 
isoelectric point, were predicted to be macrophage capping protein (P40121). Based on the 




study published by Burillo et al.
193
, the difference in the isoelectric point was due to the 
presence of an amino acid change: Arg335His. This amino acid change observed was due to a 
SNP present in the gene, rs6886 (G/A). Thus this could be an explanation for the difference in 
the expression between the volunteers (Fig. 27). 
 
5.2.6 Effect of EC-G2 and the plasma metabolites on human monocytes 
Based on the results of Koga et al.
191
, in order to understand if the protein changes observed 
were caused specifically by the bioactive substances present in chocolate, an analysis on 
human monocytes treated with concentrated plasma samples before and after the administration 
of dark and white chocolate, was performed. Even in this case, the presence of glucuronides of 
epicatechin was confirmed only after the consumption of dark chocolate (Fig. 28).  
As you can see in the figure 29, on the basis of these results, a correlation between previous 
observations using the in vivo model, cannot be made. 
The only potential correlation to previous results, is the spot identified as Rho GDP 
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Table 1. Characterization of dark chocolate bars. Quantification data of the compounds identified in the 
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Figure 18. Chromatograms of plasma samples collected after chocolate bars intake. (-)-EC glucuronide 











Figure 19. Chromatogram performed on plasma samples 4 hours following administration with white 
chocolate  (7 chocolate bars). The peak with a retention time equal to 6.6 minutes is absent.  
 




























104 p< 0,05 26.8 4.9 Grancalcin P28676 M. Jin et al., 2006
1101 p< 0,01 27.5 4.9 Grancalcin P28676 M. Jin et al. , 2006
1102 p< 0,05 26.8 5 N/D -
1104 - 26.8 5 Rho GDP-dissociation inhibitor 2 P52566 M. Jin et al. , 2006
1106 p< 0,01 26.7 5.1 Rho GDP-dissociation inhibitor 2 P52566 M. Jin et al. , 2006
2202 p< 0,01 32.4 5.4 N/D -
3101 - 30.2 5.4 N/D -
3104 - 32.3 5.5 N/D -
3105 - 30.1 5.5 N/D -
4201 - 32.4 5.5 N/D -
4204 p< 0,05 32.2 5.6 N/D -
4104 - 32.1 5.6 N/D -
4107 - 30.1 5.6 N/D -
3203 - 32.5 5.5 N/D -
3807 p< 0,05 75 5.4 N/D -
4808 - 75 5.5 N/D -
4809 p< 0,05 75 5.5 N/D -
4805 - 75 5.6 N/D -
4807 - 75.1 5.6 N/D
5401 p< 0,05 42.3 5.7 Macrophage capping protein P40121
M. Jin et al. , 2006; H.S. 
Gadgil et al., 2003
5403 p< 0,05 42.3 5.7 Macrophage capping protein P40121
M. Jin et al. , 2006; H.S. 
Gadgil et al., 2003







































Figure 20. Representative image of two-dimensional analysis of proteins (IEF: pH 5-8, SDS-page 12% 
polyacrylamide) of extracted human monocytes at baseline (fig. A) and after 3 hours following the 

















Table 2. Some significantly modulated human monocyte proteins after dark chocolate administration . 
A B 
C 




























































Figure 21. Statistical analysis of the protein spots between the three different condition; the blue 
squares (T0 versus T3 dark), the green cross (T0 versus T3 white), and the red triangle  (T3 dark versus 
T3 white) indicate the spots with significant differences (p<0,01). the colored rectangle indicate the 
cluster of protein with the protein spots that change between before and after the chocolate 
















Figure 22. Schematic representation of the protein cluster A. a) two-dimensional gel (IEF: pH 5-8, 
SDS-page 12% polyacrylamide) of extracted human monocyte proteome; the colored rectangle indicate 
the protein spots that change between baseline and after the chocolate administration. b) density 
analysis of the protein spots, (* = p<0,05; ** = p<0,01; PDQuest estimation). Enlargement and the 
three-dimensional reconstruction of the area of the 2D-gel which includes the protein spots at baseline 































































































Figure 23. Schematic representation of the protein cluster B. a) two-dimensional gel (IEF: pH 5-8, 
SDS-page 12% polyacrylamide) of extracted human monocytes proteome; the colored rectangle 
indicate the protein spots that change between baseline and after the chocolate administration. b) 
density analysis of the protein spots, (* = p<0,05; ** = p<0,01; PDQuest estimation). Enlargement and 
the three-dimensional reconstruction of the area of the 2D-gel which includes the protein spots at 














Figure 24. Schematic representation of the protein cluster C. a) two-dimensional gel (IEF: pH 5-8, 
SDS-page 12% polyacrylamide) of extracted human monocytes proteome; the colored rectangle 
indicate the protein spots that change between baseline and after the chocolate administration. b) 
density analysis of the protein spots, (* = p<0,05; PDQuest estimation). Enlargement and the three-
dimensional reconstruction of the area of the 2D-gel which includes the protein spots at baseline (c) and 














































































Figure 25. Schematic representation of the protein cluster D. a) two-dimensional gel (IEF: pH 5-8, 
SDS-page 12% polyacrylamide) of extracted human monocytes. b) density analysis of the protein spots, 
(* = p<0,05; ** = p<0,01; PDQuest estimation). Enlargement of the 2D-gel area which includes the 
protein spots at baseline (c,f) and after 3 hours following the consumption of 7 dark (d,g) and white 















Figure 26. Western Immunoblot with Rho GDP-dissociation inhibitors antibody on 2D-gel before (A) 



















Figure 27. Western immunoblot with macrophage capping protein antibody on 2D-gel.  Variability of 





















Figure 28. Chromatograms performed on concentrated plasma samples before (a) and following the 
administration with white (b) and dark (c) chocolate bars (7 chocolate bars). The peak with a retention 
time equal to  6.6 minutes only after dark chocolate consumption may be  the peak of the EC-G2. 
 
 




































Figure 29. Representative image of two-dimensional analysis of proteins (IEF: pH 5-8, SDS-page 12% 
poly-acrylamide) of isolated human monocytes at baseline (a) and after an incubation of plasma 






























SSP 4201 PROT SCORE MASS Mr COVERAGE scor+cover
883 CE047 44 19194 85 129
934 CE047 48 19194 78 126
1294A KIF2A 58 79905 19 77
1294B LCE3E 45 9500 26 71
1450 RAB13 48 22760 44 92
2325 RSLAB 42 23214 25 67
4961 CCD84 48 37950 46 94
5018 FMR1N 53 29221 33 86
SSP 3203 PROT SCORE MASS Mr COVERAGE scor+cover
883 RND3 49 27351 19 68
931 YH009 42 34143 50 92
1297A RM34 64 10159 43 107
1297B MED19 61 25257 14 75
1297C VEGFA 52 27024 16 68
1923 SMYD5 48 47310 10 58
2317 MSGN1 40 20765 28 68
4973 EDN1 54 24409 58 112
SSP 3101 PROT SCORE MASS Mr COVERAGE scor+cover
883 PHF13 50 33560 33 83
931 PHF13 46 33560 34 80
1301 LCE3E 53 9500 20 73
1450 IGF1 39 21827 45 84
2325 KCNE3 32 11703 28 60
2637 HAND1 46 23612 23 69
3277 TFPI2 40 26916 27 67
4976 U2AF1 52 27854 37 89
SSP 1102 PROT SCORE MASS Mr COVERAGE scor+cover
881 PRR13 46 15375 27 73
1292 VEGFA 52 27024 20 72
2323 SPIC 39 29162 20 59
4969 FUND2 53 20663 46 99
SSP 2202 PROT SCORE MASS Mr COVERAGE scor+cover
885A NRL 80 25924 40 120
885B H1FNT 56 28099 72 128
1257 RM34 55 10159 42 97
1450 PHF13 49 33560 25 74
1565 RBM8A 44 19877 21 65
1967 PTTG 51 20310 37 88
2931A PAGE3 60 12472 24 84
2931B PRR15 49 13707 18 67
3282 UB2D2 48 16724 31 79
4713 CT455 45 21132 40 85
Table 3. The results of peptide mass fingerprint (PMF) obtained from the mass were subjected to 
proteomic investigation program on-line MASCOT. The results showed a score greater than or equal to 

























Diet is a key environmental factor affecting health and the incidence of many chronic 
diseases
26
. Food and beverages are the only physical matter we take into our body, if we 
disregard the air we inhale and the drugs we may have to utilize. It is therefore logical and 
natural that nutrition exerts the strongest life-long environmental impact on human health. In 
fact, this interplay between nutrition and health has been known for centuries
6
. Understanding 
how our diet and nutritional status influence the composition and dynamic operations of our 
gut microbial population, and the innate and adaptive arms of our immune system, represents 
an area of scientific need, an opportunity and a challenge
8
. The concept that food components 
can affect physiological functions by interacting and modulating molecular mechanisms has 
revolutionized the field of nutrition. The concept of developing functional foods to prevent 
disease and maintain good health, requires the identification of the biologically active 
molecules and a demonstration of their efficacy. The disciplines “nutrigenetics” and 
“nutrigenomics” have evolved to address these issue. Nutrigenomics attempts to study the 
genome-wide influences of nutrition. From a nutrigenomic perspective, nutrients are dietary 
signals that are detected by the cellular sensor systems that influence gene and protein 
expression and, subsequently, metabolite production. It is an appealing idea that a food 
commonly consumed for pure pleasure could also bring tangible benefits for health. Olive oil, 
green tea and red wine have been commonly researched in the past, but now there is growing 
interest in cocoa
39,45
. Over the centuries, the use of cacao has evolved to what we now know 
as chocolate
45,57
. Chocolate can be defined as a functional food due to its high content of 
monomeric (epicatechin and catechin) and oligomeric (procyanidins) flavanols, a sub-class of 
polyphenols, which are the most abundant antioxidants in the diet
100
. Epicatechin, the major 
polyphenol in chocolate and chocolate extracts, is a powerful inhibitor of plasma lipid 
oxidation due to polyphenol’s ability to bind to low density lipoproteins
40
. Although most of 
the studies indicate that the health benefits of cocoa or cocoa products are attributable to 
polyphenols, it should be noted that cocoa and cocoa products are not only rich in 
polyphenols, but are also rich in methylxanthines and theobromine. The possible synergistic 
interactions between flavonoids and methylxanthines are also unclear and need further study, 




Flavonoids are partly absorbed from the gastrointestinal tract in animals and humans
87
. 
Recent studies have shown that metabolites such as glucuronide or sulfate conjugates and 




methylated conjugates accumulate in plasma, whereas the unconjugated compounds are 
detected in very low concentrations
79
. Conjugated metabolites have been suggested to play 
greater roles in the biological activity of flavonoids than their parent compounds. 
Nevertheless, little is known about the biological activities of the metabolites of flavonoids 
that are present in the blood. The precise circulating cocoa metabolites present after 
consumption, are only partially understood, as such the aim of the study was to understand if 
after a dark chocolate ingestion, there was an accumulation or a time-dependent presence of 
polyphenol metabolites. Based on a recent study by Goretta and co-workers
92
, an LC-MS 
analysis on plasma samples was performed using as a marker for the presence of cocoa 
metabolites in the circulating plasma, an (-)-epicatechin glucuronide, specifically the most 
abundant, 3’-glucuronide
92
. Although our analytical method for the bioavailability study is 
not sufficiently sensitive due to the small quantities of EC-G2, the results obtained confirmed 
the presence of epicatechin glucuronide in all plasma samples from 30 minutes to 4 hours 
following the ingestion of dark chocolate. To confirm that the pick at Rt= 6.6 min is 
equivalent to epicatechin glucuronide, we also used an internal standard (IS) with the same 
Rt. Furthermore, as with the previous analysis, the glucuronide product detected by the HLM, 
confirmed the results. At present, it is not possible to quantify the plasma concentration of 
EC-G2, due to the lack of commercially available standards as well as the cost of production, 
with those in possession not willing to make them available.  
It is very difficult to predict the effects of polyphenol intake on disease prevention in humans, 
because most polyphenols exert an antioxidant action in vitro, however, this does not mean 
that all polyphenols have an antioxidant effect in vivo
39
. The results thus obtained were 
expected to show if a strong association or correlation of activity in humans is possible or 
not, since data from human investigations are rare. Of these limited studies, the data support a 
role for polyphenols in the prevention of cardiovascular diseases, cancers, neurodegenerative 
diseases and diabetes
100
. However, from these studies it is very difficult to predict the long 
term effects of polyphenol intake on disease prevention in humans
65
. Experimental data is 
now accumulating regarding phenolic compounds as natural phytochemical antioxidants that 
possess anti-inflammatory effects
123
. Dietary components appear in complex mixtures and 
hence not only the concentrations of single compounds but also the interactions between 
them have an impact on the final bioavailable ingredients and the bio-efficacy
28,69
. Thus, the 
precise mechanism/s by which flavonoids exert positive effects have yet to be elucidated. 
Studies on health effects of polyphenols from cocoa or chocolate and/or other cocoa products 




are few. We need biomarkers of the function of dietary components to elucidate how they 
function in acute and in chronic conditions.  
Proteomics has logically developed as a central platform in nutrigenomics, which attempts to 
holistically understand how our genome is expressed in response to diet. Monocytes and 
macrophages are key to the inflammatory status and offer an important model in investigating 
the role of dietary components and their metabolites because they are involved in a several 
physiological processes. Another reason for this choice of cell model was determined by the 
simplicity and non-invasive sampling from human subjects. In the present study, a proteomic 
analysis of monocytes isolated from peripheral human blood was performed to examine the 
mechanisms by which chocolate consumption may modulate the monocyte/macrophage 
proteome in healthy subjects in the order to plan future functional studies. We analyzed the 
effects of cocoa polyphenols on monocyte proteomic profile to identify proteins that alter 
their expression following the consumption of chocolate. According to the LC-MS results, 
the time collection selected was between 3 and 4 hour following the ingestion of chocolate. 
We speculated that if there were metabolites in the plasma, they could act as a stimulator or 
inhibitor of protein expression in circulating cells, including monocytes. 
A clear relationship between the nutrition-related metabolic changes and inflammatory gene 
expression profiles has been found
198
. Despite their biological importance, limited 
information exists regarding the proteins expressed in peripheral blood mononuclear cells 
(PBMCs) by a 2-DE approach. In fact, a proteomic database of monocytes exists only for pig. 
The use of this technique for the separation of proteins presents a valid tool due its high 
degree of resolution and its ability to examine multiple changes at one and the same time. 
This method was used to identify proteins that could be used as potential therapeutic marker. 
Following their extraction, proteins were separated by 2D electrophoresis and their protein 
profiles analyzed by PDQuest. The analysis of statistical data has allowed us to detect 
differences in the protein profiles following consumption of dark chocolate and led to the 
identification of 11 different spots. These spots were excised and proteolytically digested 
with trypsin and analyzed through mass spectrometry. Some spots were not considered to be 
identifiable by MS due to their spot intensity. Mass spectrometry requires that the protein 
spot must be visible by coomassie staining, rather than Sybro Ruby stain which has a 100-
fold higher level of sensitivity.  
To overcome this problem are ongoing further analysis in order to optimize the method of 
proteolytic digestion, modifying the times and temperatures in which the enzymatic reaction 
happens. 




Proteomics is a very useful technique which allows researchers to study the actual output of 
the cells rather than just the DNA blueprints but as every technique has its disadvantages 
such as: only the detection of proteins more expressed, long times of work and the 2D gels el 
may not be reproducible. 
Due to the lack of a current protein database on monocytes, to identify the single spots while 
waiting for the mass spectrometry data, reference was made to results published in literature 
to date. In particular Gadgil et al.
197
, Pabst et al.
198
 and Jin et al.
193
 ,offer the most detailed 
current monocyte proteomic database and provide new perspectives into the study of 
monocyte biology. By examining the layout of the spots on the 2D-gels, the estimated 
isoelectric point and molecular weight, predictions were made as to the identify of 
significantly variable proteins pre- and post-chocolate consumption. With antibodies specific 
to these predicted proteins, a WIB analysis of 2D-gels was able to identify these proteins. The 
first protein positively identified was the Rho GDP-dissociation inhibitors (GDIs), an 
endogenous inhibitor of Rho GTPases, which play an important role in regulating the 
biological activities of rho GTPases. GDIs form a complex with the GDP-bound form of 
RHO family of small G proteins and inhibits their activation. 
There are three regulators of Rho GTPase activity. First, the conversion from the inactive 
GDP-bound form to the active GTP-bound form, is catalyzed by upstream guanine nucleotide 
exchange factors, GEFs. Second, the intrinsic GTPase activity of Rho GTPases is stimulated 
by GTPase-activating proteins (GAPs) and results in the hydrolysis of the bound GTP to 
GDP and consequent inactivation. The third type of regulators of Rho GTPases, the guanine 
nucleotide dissociation inhibitors (GDIs), interact and stabilize the GDP-bound form to 
prevent spontaneous activation. The interaction of GDIs with the prenylated form of Rho 
GTPases plays a critical role in the regulation of the cytosolic versus membrane distribution 
of Rho-GDP and also protects them from degradation. Rho GDIs possess at least two 
biochemical functions. First, they preferentially interact with the inactive, GDP-bound form 
of the Rho family and prevent them from being converted to the active form; second, after the 
inactivation of GTP-bond form, Rho GDIs  form a complex with the inactive form and 
translocate it from the membrane to the cytosol. The small G proteins of the Rho family 
consisting of Rho, Rac and Cdc42 subfamiles, are implicated in various cell functions, such 




There are three isoforms: Rho GDIα, β and ϒ. The first one is ubiquitously expressed, GDIβ 
is expressed exclusively in hematopoietic tissues and the last one is preferentially expressed 




in brain. Studies available in the literature agree that it is possible that it is involved as a 
common component for the pathogenesis of several cardiovascular disorders including 
hypertension, coronary and cerebral vasospasm, atherosclerosis and diabetes
194,199
.  
Another protein spot from the proteomic analysis that drew attention with a differential 
protein expression in the studied subjects, was predicted and identified to be macrophage 
capping protein (CapG). It belongs to the gelsolin family of proteins binding to actin in a 
calcium-dependent manner. CapG is a specific capping protein for macrophage and 
macrophage-like cells. One of their roles is to block the barbed ends of actin filaments 
without severing preformed actin filaments, a step that is critical for regulating actin-based 
motility in non-muscle cells. CapG null macrophages show impaired receptor-mediated 
ruffling, phagocytosis and vesicular rocketing
197
. These processes play critical roles in the 
function of macrophages. CapG also binds to phosphatidylinositol-4,5- bisphosphate with a 
strong affinity and it is thought to regulate receptor-mediated phosphoinositide turnover and 
calcium signaling
197
. Dupont and co-workers
200
 showed a correlation between the oxidation 
of LDL (oxLDL) and CapG. After oxLDL stimulation, expression of cytoskeletal and related 
proteins increased. These include, for example, gelsolin (3.3-fold up-regulation over control 
cells), which is involved in cell growth and maintenance and is an essential component of the 
cytoskeletal machinery. 
There is another protein probably identified by comparison with the published proteomic 
data, the grancalcin, which may play a role in the formation of focal adhesions. Because the 
significance was detected after a reworked analysis of our data, it was decided to confirm the 
spot without WIB but through the mass spectrometry
201
.  
Overall, with this analysis it can be hypothesized that after administration of dark chocolate 
there is a component/s in the plasma that promotes the expression of specific proteins 
involved in the inflammatory pathway. To test whether the protein spots examined change 
their expression following administration of dark chocolate will proceed with an analysis of 
in vitro, by treating human monocytes, and monocyte-derived macrophages (MDMs) with (-
)-epicatechin; and in vivo by assessing whether a chronic administration, at lower doses of 
chocolate, it will be able observe the same changes in the protein spots. 
For the moment, in the present study all of the attention has been given to intracellular 
proteins of monocytes. It will be very interesting to also evaluate what the cell releases into 
the culture medium following treatment with the metabolites of epicatechin. In response to 
various pathological and physiological signals, the cells produce a wide range of biological 
products, known collectively as the “secretome”, including cytokines, coagulation factors, 




growth factors, adhesion and binding proteins, enzymes, stress proteins, and signaling 
molecules. Research evaluating these secreted proteins could be a valid method in to find 
new biomarkers on which to study new therapeutic strategies. 
It is important to recognize that diet cannot replace drug treatments but offer an important 
aspect to consider for long term health benefits. This has been demonstrated by the Kuna 
Indian population, who live on islands off the coast of Panama and consume by tradition 
large amounts of cocoa daily, have lower blood pressure values and a reduced cardiovascular 
risk as compared with other Pan-American populations. As such, information regarding the 
bioactive substances present in foods such as cocoa that are normally conveyed throughout 
the body, to which tissues and at which level they act within the cellular systems are needed. 
The current study using a proteomic approach, approaches this question and holds promise 
for revealing more about how bioactive substances present in food, in this case (-)-
epicatechin, may affect the activity of human monocytes and as such the inflammatory 
pathway/s. Even though its nutraceutical value and its possible beneficial effects have been 
sufficiently described, a clear conclusion regarding the direct effect in humans has not yet 
been clarified. Hence, studies such as the present are essential for designing future treatment 












































6. AIM OF THE STUDY II 
Modern nutrition science explores the health-related aspects of bioactive food components, 
thereby promoting health, preventing or delaying the onset of disease, optimizing 
performance and assessing the benefits and risks in individuals and in subpopulations. In 
recent years, a growing number of studies, mostly conducted in vitro or ex vivo, have 
demonstrated that flavanols share the capacity to modulate inflammation as well as other 
major metabolic and immunological pathways. To date, most of the work in vitro with 
flavonoids have been carried out on neuronal and epithelial cells, but very little is known 
about the cytoprotective activity of flavonoids on immune cells.  
The main target of this research is to study the key molecular mechanisms through which the 
bioactive components of cocoa may modulate the inflammatory state. One of the principal 
bioactive components of cocoa, (-)-epicatechin (EC), was tested in time and dose-dependent 
experiments, using the U937 cell line which has been widely used as a powerful in vitro 
model to analyze the modulatory effect of substances on the inflammation. The U937 cells 
were preincubated with 100 µM of epicatechin for 30 min to 3 hour followed by the presence 
of lipopolysaccharide (LPS, 1 µg/mL) for the last 6 hour, following which nuclear and 
cytoplamatic fractions were isolated. Aliquots of each protein extract were evaluated by 
western immunoblot using anti-NRF2, anti-p NRF2, anti-NRF1, anti-HO-1 and internal 
controls to investigated a possible involvement of the transcriptional factor NRF2 in the 
molecular mechanisms activated by flavonoids in a monocytic-like cells. 




6.1 MATERIALS AND METHODS 
6.1.1 Cells culture condition  
The human monocyte cell line, U-937, were purchased from the American Type Cell 
Collection (ATCC, Rockville, MD) and maintained in RPMI 1640 supplemented with 10% of 
heat-inactivating Fetal Bovine Serum (FBS), 100 U/mL of penicillin/100 μg/mL 
streptomycin (Sigma-Aldrich) in a humidified atmosphere of 5% CO2 at 37 °C. The U-937 
cell line was chosen because it is a well-established human cell line with numerous 
monocytic characteristics and has been used extensively as an in vitro model for macrophage 
stimulation. Besides has, unlike other cell lines of monocyte-macrophages, an available 
proteomics database. Monocyte-like cell line U-937 activated by lipopolysaccharide (LPS), is 
a model often used to analyze the modulatory effect of substances on inflammation.  
6.1.2 MTT cell survival assay 
U937 cells were plated at density of 1x10
5
 cells/well in 96-well plates and treated with or 
without increasing concentrations of  (-)-epicatechin (0, 5, 10, 50, 100, 200, 500 µM). Cells 
were incubated with MTT solution 1mg/mL for 3 hours and after solubilization in DMSO, 
the absorbance at 570nM was measured. Experiments were performed in duplicate with each 
data point representing the mean ± S.D normalized to the value of control cells. 
6.1.3 U937 experimental set up  
To study the time-course effects of epicatechin, cells were seeded in T75cm
2
 flasks in 
presence of RPMI-1640 serum-free medium for 24 h before the assay, to exclude the effect of 
factors found in the fetal bovine serum which may influence the results. Subsequently, cells 
were pre-incubated with 100µM of epicatechin, according to the results of MTT assay, at 
different incubation times (0, 30, 60, 120, 180 min), followed by a stimulation with 1µg/mL 
of LPS (from E. Coli 055:B5) for 6h. Lipopolysaccharide, the main cell wall component of 
gram negative bacteria, strongly induces the production and release of various cytokines and 
inflammatory factors that initiate the inflammation process. The primary inflammatory 
response induced by gram-negative bacteria involves activation of the innate immune system. 








6.1.4 Western Immunoblotting 
To study the activation of NRF2 pathway, U937 cells were incubated as described 
previously. Nuclear and cytoplasmic proteins were extracted by a Paris Kit (Ambion). Protein 
concentration was determined using BCA reagent (Pierce, USA) according to the 
manufacturer’s instructions. As described previously, membranes were incubated at 4 °C 
with control antibodies, anti-lamin B (LamB C-5: sc-365962; Santa Cruz, CA, USA) and 
anti-α-tubulin and β-actin (Sigma-Aldrich), or for proteins of interest including anti-NRF2 
(C-20, sc-722), anti-NRF2 (H-300, sc-13032), anti- Nrf1 (NRF1 H-4: sc-28379), anti-Heme 
Oxygenase 1 (HO-1 23: sc-136256) and anti-NRF2 (phospho S40) antibody (EP1809Y; 
Abcam). After an overnight incubation and subsequent washes, the membranes were 
incubated with the appropriate horseradish peroxidase (HRP)-conjugated secondary antibody 
diluted 1:5000 in TBST for 1 h at 37 °C. Immunoreactive proteins were visualized by  
enhanced chemiluminescence (ECL) detection system (Pierce Biotechnology; Rockford, IL) 
according to the manufacturer’s instructions using Quantity One 1D image analysis software.  
6.1.5 Measurement of free radical scavenging activity 
ROS scavenging activity was determined using DCFDA Cellular ROS Detection Assay 
(ab113851; Abcam). This assay uses the florescent 2’,7’-dichlorofluorescein diacetate 
(DCFDA), a fluorogenic dye that measures hydroxyl, peroxyl and other ROS activity within 
the cell. After diffusion into the cell, DCFDA is deacetylated by cellular esterases to a non-
fluorescent compound, which is later oxidized by ROS into 2’, 7’-dichlorofluorescin (DCF). 
Detection involved fluorescent spectroscopy with excitation and emission of 485 nm and 520 
nm respectively. U937 cells were plated at density of 1x106 cells in T25cm2 flasks and 
treated with or without 100 µM of  (-)-epicatechin, followed by 1µg/mL of LPS. Experiments 
were performed in triplicate with each data point representing the mean ± S.D normalized to 
control cells. 
6.1.6 Measurement of cytokines and chemokines 
The multi analyte ELISArray Kit are designed to simultaneously profile the level of multiple 
cytokines and/or chemokines using the conventional and simple Sandwich-Based Enzyme-
Linked Immunosorbant Assay (ELISA) technique according to the manufacturer's 
instructions. The 96-well ELISA microplate has been coated with a panel of target-specific 
capture antibodies giving a qualitative profile for up to six samples. The cytokines and 




chemokines represented by these array are IL-1α, IL-1β, IL-2, IL-4, IL-6 IL-10, IL-12, IL-
17α,IFNϒ, TNFα and GM-CSF. The serum-free medium of the control group (U937 cells 
alone, with LPS 1µg/µL, the vehicle and the bioactive substance) and after the incubation 
with both epicatechin (100 µM) and LPS (1µg/mL) for 6h and 24h were collected and used 
for the analysis. Absorbance was read at 450 and 570 nm. Experiments were performed in 
duplicate with each data point representing the mean ± S.D normalized to control cells.   
6.1.7 Statistical analysis 
Data are expressed as mean ± SD. Skewed variables were logarithmically transformed before 
analyses when necessary. Differences between groups, treatments and in vitro studies were 
compared using Mann-Whitney U or Wilcoxon test, Student’s t test and χ
2
 test when 
necessary. Statistical significance was assumed for p<0.05. The statistical analyses were 
performed with GraphPad Prism for Windows. 
 




6.2. RESULTS  
6.2.1 MTT cell survival assay 
To assess the cytotoxic effect of various concentrations of epicatechin on the cell line U937, 
an MTT assay was performed (fig. 30). As shown, increasing concentrations of epicatechin 
reduced the cell viability to between 79 and 38%, but only with the three highest 
concentrations (200, 400 and 500 µM). With respect to the lower concentrations, cell 
viability was always greater than 80%. As such, all subsequent experiments on U937 cells 
were done with a 100 µM concentration of epicatechin. 
6.2.2 Western Immunoblotting 
To explore the possible intracellular mechanism of (-)-epicatechin (EC), cellular stress on 
U937 cells was induced with LPS and we investigated the expression of a profile of proteins 
involved in oxidative stress. In particular, focus was given to the expression of the 
transcription factor NRF2, demonstrated to be a critical regulator of flavonoid-mediated 
protection. 
As expected, NRF2 was expressed exclusively in the cytosol of untreated cells and did not 
undergo nuclear translocation with LPS or EC alone (fig. 31 a). Alternatively, when treated 
with both LPS and EC, there was a time dependent increase in whole cell NRF2 levels with 
respect to controls, as shown in figure 32 a, b.  Further, analysis of both the cytosolic and 
nuclear compartments showed that pre-treatment with epicatechin and a subsequent 6h of 
stimulation with LPS, increased in time dependent manner the nuclear translocation of p-
NRF2 (S40) in figure 33. To further investigated the potential role of NRF2 from the 
perspective of a defense mechanism induced by oxidative stress, the expression of Heme 
oxygenases-1 protein downstream of NRF2 was evaluated
202
. While the expression levels are 
very low, as shown in figure 34, the preliminary results show a 30% up-regulation of HO-1 in 
nuclear compartment after EC and LPS incubation, with respect to the control cells.  
The involvement of NRF1 was also investigated, being that NRF1 has been shown to bind to 
ARE and regulate the expression of a number genes involved in oxidative stress. In figure 35, 
despite the fact that LPS alone and EC express a consistent level of Nrf1 mainly in the 
cytosolic compartment, it can be seen that LPS in conjunction with EC increases the total 
expression and the possible translocation of NRF1 from the cytoplasm to the nucleus. What is 
difficult to explain at the present moment and is awaiting further experimentation, is how (-)-




epicatechin could be able to modulate Nrf1 and if the two transcriptional factor are 
interdependent.  
 
6.2.3 Measurement of free radical scavenging activity 
To establish whether ROS generation was involved in contributing to cell death after EC and 
LPS treatment, ROS levels were determined according to the fluorescence levels of 2’ ,7’-
dichlorofluorescein (DCF), in the U937 cells (fig. 36). The results demonstrate that the EC 
treatment significantly decreased ROS levels. Despite this, the amount of ROS also remained 
high even in untreated cells, when compared with LPS-treated cells. Taken together, these 
observations suggest that ROS was elevated after the LPS incubation but these levels were 
decreased following EC treatment (P< 0.05). 
 
6.2.4 Measurement of cytokines and chemokines 
To further explore the anti- or pro- inflammatory effect of EC on U937, we measured 11 
common chemokines and cytokines known to be involved in the inflammatory pathways (fig. 
37 a, b). As expected, the expression levels of all chemokines and cytokines were low in the 
control group (U937 and DMSO). These levels remained low in the EC alone treated cells as 
opposed to the LPS treatment, where a clear increase in IL-6 and TNF-α were observed. 
Treatment with both EC and LPS showed an increase in the levels of IL-2, IL-4, Il-17α and 
IFNγ, with respect to EC alone, with levels of these cytokines tending to rise with an 
increasing time of incubation with EC and LPS combined (24h). What was unusual and 
unexpected was IL-17α, which while absent in LPS and EC alone, showed a significant up-
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Figure 30. U937 cells were incubated with increasing concentrations of EC for 24 h. Cell viability 



















Figure 31.  Incubation (24 h) with EC or LPS alone (6 h) do not induce the translocation of NRF2. A) 
Representative example of  western immunoblot of  NRF2 protein expression. B) α-tubulin and 
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Figure 32. a) Cytoplasmic (C) and nuclear (N) extracts from U937 cells incubated with 100 uM of 
epicatechin (EC) for 30 min, 1, 2, and 3 hours, and then stimulated with LPS 1 µg / mL for the last 6 
hour of incubation. The proteins were subjected to western immunoblotting to detect NRF-2 (β-actin 
and Lamin β are used as a control). b) Densitometric quantification of the bands detected  (* = 
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Figure 33. a) Cytoplasmic proteins (C) and nuclear (N) extracts from U937 cells incubated with 100 
uM of epicatechin (EC) for 30 min, 1, 2, and 3 hours, and then stimulated with LPS 1 µg / mL for the 
last 6 hour of incubation. The proteins were subjected to western immunoblotting to detect pNRF-2 
phosphorylated  (α-tubulin and Lamin β are used as a control). b) Densitometric quantification of the 
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Figure 34. a) Cytoplasmic (C) and nuclear (N) extracts from U937 cells incubated with 100 µM of 
epicatechin (EC) for 30 min, 1, 2, and 3 hours, and then stimulated with LPS 1 µg/mL for the last 6 
hour of incubation. The proteins were subjected to western immunoblotting to detect HO-1 (α-tubulin 
and Lamin β are used as a control). b) Densitometric quantification of the bands detected  
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Figure 35. a) Cytoplasmic (C) and nuclear (N) extracts from U937 cells incubated with 100 µM of 
epicatechin (EC) for 30 min, 1, 2 and 3 hours, and then stimulated with LPS 1 µg/mL for the last 6 
hour of incubation. The proteins were subjected to western immunoblotting to detect NRF1 (α-tubulin 
and Lamin β are used as a control. b) Densitometric quantification of the bands detected  (mean±SD;* 




















































Figure 36. Labeled U937 cells were treated with 100 µM of EC from 1 to 5h and than incubated with 
1µg/mL of LPS for 6h. Results are expressed as the % ROS with respect to the control group 





















































































Figure 37.  The qualitative expression of cytochines and chemokines following treatment of U937 cells with LPS and EC alone and in 
combination:  a) IL-1α, IL-1β, IL-2, IL-6, IL-17α, TNFα and b) IL-4, IL-10, IL-12, IFNγ, GM-CSF. Serum-free medium of control groups 
(U937 cell alone, with LPS 1µg/uL, the vehicle and the bioactive substance, DMSO) and after the incubation with either epicatechin (EC 




























                                                                                             Experimental section II: discussion 





During this second experimental part, the attention focused on the potential involvement of 
the transcription factor NRF2 in the cellular pathway/s activated by epicatechin. A number of 
transcription factors have been connected to oxidative stress, such as NF-kB, activator 
protein-1 (AP-1) and importantly NRF2, which also modulates signaling pathways involved 
in the regulation of cell detoxification, proliferation, survival, death and differentiation. 
The nuclear factor erythroid 2-related factor 2, NRF2, is an emerging regulator of cellular 
resistance to oxidants. NRF2 controls the basal and induced expression of an array of 
antioxidant response element-dependent genes to regulate the physiological and 
pathophysiological outcomes of oxidant exposure.  
From these hypotheses, in vitro studies were performed to show a correlation between the 
activation of NRF2 and the EC treatment on the human monocytic cell line, U937. Based on 
the cytotoxicity studies, in this preliminary study, an elevated concentration of EC at 100 µM, 
was used to try to decipher if the expression of NRF2 could be observed with a limit 
concentration of epicatechin. After increasing times of pre-incubation, from 30 minutes to 3 
hours with EC, a subsequent treatment with LPS was set for the last 6 hours
203
, which is a 
sufficient enough time to allow intracellular expression of NRF2 targeted proteins such as 
HO-1
204
. The results showed a time-dependent translocation of activated NRF2, 
corresponding to phosphorylation at Ser40. This is in agreement with previously studies 
which hypothesized that the phosphorylation of Ser-40 with oxidative stress, can be regulated 
by PKCδ, resulting in the dissociation of NRF2 from its cytoplasmic inhibitor KEAP1, thus 
promoting its translocation into the nucleus
205
. Therefore in addition to trialing lower 
concentrations of EC which are more realistic to a diet containing this component, an 
investigation of PKCδ, one of the enzymes responsible for the phosphorylation of NRF2, and 
KEAP1 will be performed to understand if they have in fact an active role. Known 
downstream targets of NRF2 including HO-1 were investigated. However the results of the 
activation of the enzyme downstream were unsatisfactory. Because, therefore it is an 
inducible stress protein, it was detected also in untreated cells. This is probably due the type 
of inflammatory cells chosen, which have always a certain type of latent activation, at the 
moment there are no data in literature about this observation. Thus, to obtain more 
satisfactory results, it may be necessary to perform an immunoprecipitation to isolate the 
enzymes prior to the WIB analysis. In addition, other enzymes expressed followed activation 
of NRF2, such as phase I and II metabolizing enzymes and detoxifying proteins, such as 
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NAD(P)H:quinone oxidoreductase 1 (NQO1) and Glutathione S-transferases (GST) should 
also be investigated. To verify if it was actually epicatechin to modulate the expression of 
these proteins will be performed the same experiments using the EC or LPS treatments alone, 
and not at the same time as it has been presented in this second experimental part. Moreover, 
as reported by the team of Biswal, to demonstrate whether NRF2 accumulated in the nucleus 
by EC actually binds to the ARE, the ARE-binding complex with NRF2 antibody using an 
electrophoretic mobility shift assay supershift (EMSA) should be performed
206
. It has also 
been suggested that NRF2 responds to inducible oxidative stimuli and that NRF1 regulates 
more constitutive forms of oxidative stress, however both are responsible for regulating the 
expression of many antioxidant genes
207
. Currently, the mechanisms controlling NRF2 
activity have been studied, while studies examining Nrf1 regulation are lacking. For this 
reason it was decided to check whether following incubation with LPS and EC there was also 
the activation of NRF1. As for NRF2, there was increase in the translocation of NRF1 from 
the cytoplasm to the nucleus, paralleled by an overall increase in its total protein expression. 
Recent studies have established NRF1 as a pivotal transcriptional regulator of the genes of 
the proteasome subunits and the synergistically combining activities of NRF1 and NRF2 may 
protect cells during cellular stresses and may enable both normal and cancer cells to survive 
in toxic environments
208
. Then after observing the activation of NRF2, we would like to 
check the reduction of ROS following incubation with the flavonoid. We demonstrated that 
LPS-induced ROS expression was down-regulated by EC treatments in a time-dependent 
manner. Alternatively, in the presence of LPS alone and even untreated cells, ROS levels 
were sustained. ROSs are produced normally during the respiratory burst of phagocytes as a 
defense mechanism against pathogens. However, as showed by Irani
209
, ROSs also in non-
stressed condition regulate multiple cellular functions such as growth, differentiation, 
proliferation, apoptosis and gene expression. These results support the antioxidant role of the 
bioactive substance. Considering that ROS are regulators of apoptosis and that there is a 
network of communication between the systems of regulation anti-oxidants and those pro-
oxidants
209
, it would be interesting to evaluate this signaling pathway to understand if EC 
could have a potential role in this pathway. Further, to understand whether the results can be 
attributed to the activation of NRF2, it will be necessary to block the activation of the 
transcription factor or use RNA interference to determine whether the investigated pathways 
are activated in response to stress stimuli or incubation with the flavonoid.  
The preliminary results presented in the current study support the concept of the anti-
inflammatory activity of EC. Thus, we evaluated also the inhibition of the pro-inflammatory 
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cytokines and chemokines. The results obtained support this hypothesis, although there is a 
progressive increase in inflammatory cytokines with increasing time of incubation with LPS, 
which evidently shows a dominant effect with respect to the action of epicatechin. In fact it is 
wildly recognized that LPS activated the tool-like receptor (TLRs) which are now implicated 
in a number of acute and chronic inflammatory diseases
210
. Additional analyzes will be 
needed using traditional ELISA kits to evaluate the single cytokines that show changes, in 
particular IL-17α, present exclusively and repeatedly in the treatments with EC and LPS at 
24h. This observation are in accordance with the research performed by Zizzo et al.
211
, where 
they reported that the presence of IL-17 prevents monocyte/macrophage apoptosis and the 
restoration of anti-inflammatory conditions
211
.  
These preliminary results provide attractive details on how flavonoids could modulate the 
activation of NRF2, with the battery of down-streaming genes related to it, and their effect on 
the ROS level into monocytes. Understanding how the bioactive substances present in the 
diet are able to modulate the inflammatory state at the cellular level require further 
investigations. Consequently, further efforts are needed to elucidate the benefits and the risks 
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